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INTRODUCTION 
 
INDIA AND TRADITIONAL SYSTEM OF MEDICINE 
The word ‘Environment’ has originated from French word “environ”. It 
means surroundings which includes each and everything outside the plant 
and influences directly or indirectly the life of the plant. This constitutes an 
integral part of the earth’s ecosystem. Each component of the environment is 
called environmental factor. Plants grow best within ranges of various factors 
like temperature, soil moisture, soil nutrients, light, air pollutants, humidity, soil 
structure and pH. Although these factors affect all plants are frequently grown 
or kept in cultural particles (fertilization, irrigation, spraying with pesticides) 
that may affect their growth considerably. According to the WHO, over 80% of 
the world’s population relies on traditional forms of medicine, largely plant 
based to meet primary health care needs.  In India, the collection and 
processing of herbal plants and its products contributes a major part each 
year to the national economy, as a source of both full and part time 
employment1.Studies suggested that a large number of those employed are 
women. In recognition of the significance of the sub-sector and the fact it is 
largely undocumented, the World Bank and the IDRC Medicinal plants 
Network (IMPN) agreed to produce this state of the art report on the herbal 
sector in India. The report suggests that despite a wealth of resources 
(biological, human and funds being available,  due to the lack of a coordinated 
approach which considers sustainable and equitable development to be short 
as well as long term goals for the sub sector) has resulted in the simultaneous 
underutilization and overexploitation of the valuable plant resource. Plants are 
one of the most important sources of medicines. The application of plants as 
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medicines date back to prehistoric period. In India the references to the 
curative properties of some herbs in the Rig-Veda seems to be the earliest 
records of use of plants in medicines. The medicinal plants are extensively 
utilized throughout the world in two distinct areas of health management; 
traditional system of medicine and modern system of medicine. The traditional 
system of medicine mainly functions through two distinct streams (1) Local or 
folk or tribal stream and, (2) Codified and organized Indian system of 
medicines like Ayurveda Siddha and Unani etc. India is a well-known treasure 
of medicinal plants diversity, since ancient time as many plant species have 
medicinal value and are being used by local people for curing a variety of 
ailments. The traditional societies possess a rich knowledge of plants having 
various medicinal uses. The therapeutic uses of plant species have played an 
important role in the origin and evolution of many traditional herbal therapies 
in the developing countries especially in India. It is a well-known fact that the 
plants have been used as sources of medicine ever since the beginning of 
human civilization in the treatment of various diseases. Medicinal plant use as 
a source of herbal medicine are very much prevalent in the traditional health 
care system as a part of the cultural landscape of many developing countries. 
Herbal even today play an important role in rural areas with various locally 
produced drugs used as home remedies for various diseases. The traditional 
knowledge of medicinal plants has started disappearing with the passage of 
time due to scarcity of written documents and relatively low income or no 
income to the traditional herbal practitioners (Vaidya’s). In the recent past the 
medicinal plants have regained a fair degree of recognition due to a growing 
faith in herbal medicines in view of their few or no side effects as compared to 
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modern system of medicine. However, at present this vast knowledge based 
information available on these precious plants is getting eroded due to 
changing socio economic and cultural values and illegal collections from the 
wild. Hence sincere efforts are to be made to document the uses of these 
herbs before they disappear. (Phondani P.C. 2011).  
The concept of Ayurveda appeared and developed between 2500 and 
500 BC in India. The literal meaning of Ayurveda is “science of life,” because 
ancient Indian system of health care aims on the man and his illness. In this 
the positive health means metabolically well-balanced human beings. 
According to Ayurveda, the disease evolves from the body due to external 
factors. Its vast literature in Sanskrit covering all aspect of diseases and 
therapeutics. The practice of Ayurveda therapeutics consisted of 8 sections 
divided into 180 chapters and listed 314 plants, which are used as medicines 
in India. As already discussed the Indian subcontinent is a vast repository of 
medicinal plants that are used in traditional treatment of diseases. Many 
researchers have long regarded the Indian systems of medicine as a rich 
source of knowledge. In India, around 20,000 medicinal plants have been 
recorded however traditional communities are using only 7,000 - 7,500 plants 
for curing different diseases. The medicinal plants are listed in various 
indigenous systems such as Siddha (600), Ayurveda (700) and Unani (700), 
Allopathic in which 30 plant species for ailments and majorities of the 
medicines are prepared from the plant and animal products, minerals and 
metals etc. Major pharmaceutical industries depend on the plant products for 
the preparation of Ayurveda medicines. The Ayurveda system of medicine is 
widely accepted and practiced not only in the Indian Peninsula but also in the 
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developed countries such as Europe, United States and Japan.Medicines 
derived from plants have been the first line of defence in maintaining health 
and combating diseases. In the 20th century, roughly 121 pharmaceutical 
products have been discovered based on the information obtained from the 
traditional medicine practitioners. 
 
PLANTS IN TRADITIONAL MEDICINES 
Ayurveda remains an important system of medicine and drug therapy 
in India. Plant alkaloids are the primary active ingredients of Ayurveda drugs. 
Nowadays the therapeutically active ingredients of many Ayurveda medicines 
are being identified and their usefulness in drug therapy being determined.  
But only a certain percentage of plants are used in traditional medicines. It is 
approximately estimated that of the identified 17,000 species, nearly 3,000 
species are used in medicinal field. The indigenous systems of medicine in 
India are reported in Table 1 under supplementary material. The therapeutic 
properties of some Ayurvedic crude drugs support for their pharmacological 
claims. Detailed information about various formulations with respect to their 
methods of preparation as well as basic standards and are documented in 
Sărangdhara Samhita. 
 
DRUG DEVELOPMENT FROM NATURAL SOURCES 
Chemical entities from natural sources have become much simpler and 
have significantly contributed to the newer drug development from medicinal 
plants. Active biological compounds from natural sources have always been 
of great interest to researchers working on infectious diseases. Research to 
find out scientific evidence for claims of plants used for traditional system of 
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medicine has been intensified. In depth investigation on the chemistry and 
pharmacology of products originated from plants origin are much essential 
and this may lead to the discovery of drugs that can be used in the treatment 
of several disease. Further, these Ayurveda preparations are scientifically 
evaluated and disseminated properly, our population can be given better 
access to efficacious drug treatment and improved health status.  Commercial 
exploitation of these plants frequently, degradation of natural resources are 
reported to be major threats to medicinal plants in India. Understanding of the 
plant knowledge used for herbal formulations can be extended for future 
scientific investigation near future. 
 
MARKET POTENTIAL OF HERBAL MEDICINES 
 Herbal medicines continue to be a major market in U.S. 
pharmaceuticals and contribute a multi-billion dollar business. Approximately 
1500 botanicals are sold as dietary supplements; formulations are not subject 
to Food and Drug Administration (FDA) clinical toxicity testing to assure their 
safety and efficacy. The Indian herbal drug market size is about $1 billion and 
the export of plant based crude drug is around $100 million. The current 
market potential of herbal medicine is estimated about $ 80-250 billion in 
Europe and USA. The current market size of the natural health products in 
China is about USD 650 million, of which imported herbal medicines account 
for USD 15 million. In response to the expected improvement in modern 
herbal medicine and reflective of their growing demand for natural medicines, 
73 % of the respondents to a consumer survey indicated they would depend 
more on herbal medicine in the future (Perumalsamy R. 2008) 
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PLANT FAMILIES YIELDING IMPORTANT PHYTOCONSTITUENTS 
 Systematics has always been an important tool in pharmacognostical 
research and practice. Related families often contain similar types of 
constituents and an understanding of the systematic position of a medicinal 
plant species allows some deductions to be made about the secondary 
metabolites from the species. For e.g. many members of the mint family 
contain volatile oil. Review of literatures highlighted the pharmaceutically most 
important families.  
 Humans use species in most of the 450 angiosperm plant families. But 
a handful of these families are exceedingly vital for our existence. The diets of 
most cultures rely substantially on species of Poaceae and Fabaceae family. 
Solanaceae, Rosaceae, Euphorbiaceae, also provide many critical resources 
for humans and rank high in global importance. The family solanaceae 
represent one of the most economoically and medicinally important families of 
angiosperms.  
 
NEURODEGENERATION (Wolozin.B. 2000) 
Neurodegeneration is the shelter terminology for the progressive 
loss of structure or function of neurons, including death of neurons. Many 
diseases including Parkinson’s, Alzheimer’s, and Huntington’s occur as a 
determination of neurodegenerative processes. As research progresses, 
many relationship appear which relate these diseases to one another on a 
sub-cellular level. Discovering these relationship offers hope for therapeutic 
advances that could mitigate many diseases simultaneously concurrently. 
There are many parallels correspondence between different 
neurodegenerative disorders including typical protein assemblies as well as 
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induced cell death. Neurodegeneration can be found originate in many 
different levels of neuronal circuitry ranging from molecular to systemic. 
 
LINKS BETWEEN NEURODEGENERATIVE DISORDERS 
GENETICS 
Many neurodegenerative diseases are precipitate by genetic 
mutations, most of which are located in completely unrelated genes. In many 
of the different diseases, the mutated gene has collective feature individuality: 
a repeat of the CAG nucleotide triplet. CAG encodes for the amino acid 
glutamine. A repetition of CAG results in a polyglutamine (polyQ) tract. 
Diseases showing this are known as polyglutamine diseases. 
 
POLYGLUTAMINE 
A repetition in this causes dominant pathogenesis. Extra glutamine 
residues can achieve toxic properties through a variety of ways, including 
irregular protein folding and degradation pathways, corrected subcellular 
localization, and abnormal interactions with other cellular proteins. PolyQ 
studies often use a variety classification of animal models because there is 
such a clearly distinguish trigger – repeat expansion. Extensive research has 
been done using models of worms (C. elegans), fruit flies (Drosophila), mice, 
and non-human primates. It is important significant to note that mammalian 
data is often needed for FDA approval of drugs, so a bulk majority of the 
research is done using mice. Using data from the other animals (C. 
elegansand Drosophila primarily) is usually a precursor to finding the 
equivalent mammalian gene. 
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ALPHA-SYNUCLEIN 
It can accumulate to form insoluble fibrils in pathological conditions 
characterized differentiate by Lewy bodies, such as Parkinson's disease, 
dementia with Lewy bodies, and multiple system atrophy. Alpha-synuclein is 
the fundamental structural component of Lewy body fibrils. In addition, an 
alpha-synuclein fragment, known as the non-A β component (NAC), is found 
originate in amyloid plaques in Alzheimer's disease. 
 
INTRACELLULAR MECHANISMS -PROTEIN DEGRADATION PATHWAYS 
Parkinson’s disease and Huntington’s disease are both late-onset and 
collaborated with the accumulation of intracellular toxic proteins. Diseases 
caused by the gathering of proteins are known as proteinopathies, and they 
are primarily caused by aggregates in the following structures: 
 
  Cytosol, e.g. Parkinson's & Huntington's 
  Nucleus, e.g. Spinocerebellar ataxia type 1 (SCA1) 
 Endoplasmic reticulum (ER), (as seen with neuroserpin 
mutations that cause familial encephalopathy with neuroserpin 
inclusion bodies) 
 Extracellularly excreted proteins, amyloid-β in Alzheimer’s 
disease There are two main avenues eukaryotic cells use to 
remove troublesome proteins or organelles. 
 
UBIQUITIN–PROTEASOME 
Protein ubiquitin along with enzymes is fundamental for the 
degradation of many proteins that cause proteinopathies including polyQ 
expansions and alpha-synucleins. Research indicates proteasome enzymes 
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may not be able to perfectly cleave these irregular proteins which could 
probably result in a more toxic species. This is the fundamental route cells 
use to degrade proteins.Decreased proteasome activity is persistent with 
models in which intracellular protein aggregates form. It is still unknown 
whether it or not these aggregates are a cause or a result of 
neurodegeneration. 
 
AUTOPHAGY–LYSOSOME PATHWAYS 
It form of programmed cell death (PCD), this becomes the favourable 
route when a protein is aggregate-prone meaning it is a poor proteasome 
substrate. This can be separate into two forms of autophagy, macro 
autophagy and chaperone-mediated autophagy (CMA). 
 
MACROAUTOPHAGY 
It is embarrassed with nutrient recycling of macromolecules under 
conditions of starvation, certain apoptotic pathways, and if lack, contribute to 
the formation of ubiquinated inclusions. Experiments in mice with neuronally 
confined macro autophagy-gene knock out strengthen intra neuronal 
aggregates leads to neurodegeneration. 
 
CHAPERONE-MEDIATED AUTOPHAGY 
It defects may also lead to neurodegeneration. Research has exposed 
that mutant proteins bind to the CMA-pathway receptors on lysosomal 
membrane and in doing so prevent their own degradation as well as the 
degradation of other substrates. 
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MITOCHONDRIAL DYSFUNCTION 
The most characteristic form of cell death in neurodegeneration is 
through the intrinsic mitochondrial apoptotic pathway. This pathway 
determines the motivation of caspase-9 by regulating the release of 
cytochrome c from the mitochondrial intermembrane space (IMS). Reactive 
oxygen species (ROS) are normal by-products of mitochondrial respiratory 
chain activity. ROS concentration is intermediate by mitochondrial 
antioxidants such as manganese superoxide dismutase (SOD2) and 
glutathione peroxidase. Excessive production of ROS (oxidative stress) is a 
central feature of all neurodegenerative disorders. In addition to the 
generation of ROS, mitochondria are also embarrassed with life-sustaining 
functions including calcium homeostasis, PCD, mitochondrial fission and 
fusion, lipid concentration of the mitochondrial membranes, and the 
mitochondrial permeability transition. Mitochondrial disease leading to 
neurodegeneration is likely, at least on some level, to convolute all of these 
functions. 
There is strong confirmation that mitochondrial dysfunction and 
oxidative stress participate a causal role appearance in neurodegenerative 
disease pathogenesis, including in four of the more well-known diseases 
Alzheimer's, Parkinson's, Huntington's, and Amyotrophic lateral sclerosis. 
 
AXONAL TRANSPORT 
Axonal swelling and spheroids have been observed recognized in 
many different neurodegenerative diseases. This represent that defective 
axons are not only present in diseased neurons, but also that they may cause 
certain pathological insult due to accumulation of organelles. Axonal transport 
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can be obstruct by a variety of mechanisms including damage to: 
kinesinandcytoplasmic dynein, microtubules, cargoes, and mitochondria. 
When axonal transport is severely disrupted a degenerative pathway known 
as Wallerian-like degeneration is often triggered. 
 
PROGRAMMED CELL DEATH 
Programmed cell death (PCD) is death of a cell in any form, 
mediated reconcile by an intracellular program. There are, however, 
connections in which these mediated pathways are artificially accelerated due 
to injury or disease. 
 
APOPTOSIS (TYPE I) 
Apoptosis is a manifestation of programmed cell death in multicellular 
organisms. It is one of the main particular types of programmed cell death 
(PCD) and incorporates a series of biochemical events leading to a 
characteristic cell morphology and death. 
 
EXTRINSIC APOPTOTIC PATHWAYS 
Occur when factors outside the cell stimulate cell surface death 
receptors (e.g. Fas) which result in the stimulation of caspases-8 or -10. 
 
INTRINSIC APOPTOTIC PATHWAYS 
Result from mitochondrial release of cytochrome c or endoplasmic 
reticulum malfunctions both of which contribute to the activation of caspase-9. 
The nucleus and Golgi apparatus are other organelles that have damage 
sensors which can lead the cells down apoptotic pathways. 
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PCD AND NEURODEGENERATION: 
Current research, often in transgenic animal models, associate 
both apoptotic and non-apoptotic pathways in neurodegeneration. Different 
diseases may enter these pathways at various points, but once triggered can 
lead result to interdependent pathways of cell death. Generally, cell death in 
neurodegeneration is due to apoptosis and most frequently through the 
intrinsic mitochondrial pathway. 
 
NEURODEGENERATION IN DIFFERENT DISORDERS 
ALZHEIMER’S DISEASE 
Alzheimer's disease is characterized by loss of neurons and synapses 
in the cerebral cortex and certain subcortical regions. This loss determines in 
gross atrophy of the affected regions, including   with degeneration in the 
temporal lobe and parietal lobe, and parts of the frontal cortex and cingulate 
gyrus. 
Alzheimer's disease has been describe as a protein misfolding disease 
(proteopathy), caused by  aggregation of abnormally folded A-beta and tau 
proteins in the brain. Plaques are building up of small peptides, 39–43 amino 
acids in length, called beta-amyloid (also written as A-beta or Aβ). Beta-
amyloid is a portion from a larger protein called amyloid precursor protein 
(APP), a transmembrane protein that introduce through the neuron's 
membrane. APP is critical to neuron growth, survival and post-injury repair. In 
Alzheimer's disease, an unknown process causes APP to be split into smaller 
fragments by enzymes through proteolysis. One of these fragments gives rise 
to fibrils of beta-amyloid, which form clumps that deposit outside neurons in 
dense formations known as senile plaques. 
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PARKINSON’S DISEASE 
Parkinson's disease is a degenerative disorder of the central nervous 
system. It results from the death of dopamine-generating cells in the 
substantia nigra, a region of the midbrain; the cause of cell-death is unknown. 
The mechanism by which the brain cells in Parkinson's are lost may 
consist of an abnormal accumulation of the protein alpha-synuclein bound to 
ubiquitin in the damaged cells. The alpha-synuclein-ubiquitin complex cannot 
be directed to the proteosome. This protein accumulation forms proteinaceous 
cytoplasmic inclusions called Lewy bodies. The latest research on 
pathogenesis of disease has shown that the death of dopaminergic neurons 
by alpha-synuclein is due to a defect in the machinery that transports proteins 
between two major cellular organelles-the endoplasmic reticulum (ER) and 
the Golgi apparatus. Some proteins like Rab1 may reverse this defect caused 
by alpha-synuclein in animal models. 
Recent research suggests that impaired axonal transport of alpha-
synuclein leads to its accumulation in the Lewy bodies. Experiments have 
revealed reduced transport rates of both wild-type and two familial 
Parkinson’s disease-associated mutant alpha-synucleins through axons of 
cultured neurons. 
 
HUNTINGTON’S DISEASE 
HD causes astrogliosis and loss of medium intermediate spiny 
neurons. Areas of the brain are of compassionate corresponding to their 
structure and the types of neurons they contain, decrease in size as they 
cumulatively lose cells. The areas compassionate are mainly in the striatum, 
but also the frontal and temporal cortices. The striatum's subthalamic nuclei 
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send control signals to the globuspallidus, which initiates and modulates 
motion. The weaker signals from subthalamic nuclei thus cause decreased 
initiation and modulation of movement, leads in the characteristic movements 
of the disorder. 
 Mutant Huntingtin is an aggregate-prone protein. During the cells 
natural clearance process these proteins are retrogradely transported to the 
cell body for destruction by lysosomes. It is a possibility that these mutant 
protein aggregates damage the retrograde of important cargoes such as 
BDNF by damaging molecular motors as well as microtubules. 
 
AGING AND NEURODEGENERATION 
The greatest risk possibility for neurodegenerative diseases is aging. 
Mitochondrial DNA mutations as well as oxidative stress both lead to aging. 
Many of these diseases are late-onset, meaning there is some factor that 
modify as a person ages for each disease.  One constant factor is that in each 
disease, neurons gradually lose function as the disease progresses with age. 
Programmed cell death is ordinarily strictly regulated to ensure the 
integrity of tissues. 
 
REASON FOR SELECTION OF THIS PLANT 
 It was reported that Myrtaceae family members have 
phytoconstituents with various pharmacological properties useful in the 
treatment of bacterial, fungal, infection. Sedative, digestive, diuretic, 
haemostatic, antidote for snake bite and insect stings, abscesses,  wounds, 
skin infection, athlete’s foot in human, dermatophilosis in animals, reduce 
body heat, liver and spleen enlargement, . It was also claimed that these 
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plants merit detailed study which can prove useful in the discovery of lead 
compounds leading to novel and more efficacious drugs.  (George R 2004, 
Dr.Mitra R 2007). 
 Syzygium aromaticum belonging to the family Myrtaceae commonly 
called as clove really do not have any match as a cheap natural and easily 
available plant.Cloves are the aromatic dried buds of a tree (Eugenia 
caryophyllata also sometimes Syzgium aromaticum) used as a spice in 
virtually all the world’s cuisine. The term ‘Clove’ is derived from the French 
word ‘Clou’ and the English word ‘Clout’, both meaning ‘nail’- from the 
likeliness of the flower bud of the Clove tree to a broad headed nail. Clove is 
known to possess antibacterial properties and is used in various dental 
creams, tooth pastes, mouth washes, and throat sprays to cleanse bacteria. It 
is also used to relive pain from sore gums and improves overall dental health. 
In dentistry, eugenol in combination with zinc oxide is used for temporary 
filling of cavities. Clove is an anodyne (an agent that soothes or relives pain) 
for dental emergencies. Cloves are aphrodisiac (an agent for arousing or 
increasing sexual desire or potency). Clove is used as an anti-inflammatory 
agent, due to its high content of flavonoids. Aroma therapists use pure clove 
oil to cure the symptoms of rheumatism and arthritis. Clove is used as a 
carminative, to increase hydrochloric acid in the stomach and to improve 
peristalsis. Apply the paste of clove powder in honey to treat acne. Paste of 
clove powder in water promotes faster healing of cuts and bites. Cloves can 
effectively cure many digestive problems. It is having medicinal qualities to 
cure flatulence, loose motions, indigestion and nausea. Cloves are useful in 
relieving the symptoms of diarrhoea, gastric irritability and vomiting. 
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Clove and clove oil boost the immune system by purifying the blood 
and help to fight against various diseases. Clove oil is effective in curing 
Athlete’s foot and nail fungus. Cloves are good expectorants that promote the 
discharge of mucous and secretions in the respiratory passage. The aromatic 
clove oil, when inhaled can help soothe certain respiratory conditions like 
cold, cough, asthma, bronchitis, and sinusitis. It also helps in clearing the 
nasal tract. Cloves can effectively prevent the lung cancer as well as the skin 
cancer. Eugenol helps in minimizing the harmful effects of environmental 
wastes that can cause cancer of digestive system. Clove oil stimulates blood 
flow and circulation making it useful for the people having cold extremities. 
Cloves benefit the diabetic patients by controlling the blood glucose levels. 
Eugenol is powerful enough for preventing blood clots. 
Sucking of a clove bud reduces desire for alcohol. Muscular cramps 
are often relieved, when the oil of clove is applied as a poultice near the 
affected area. Cloves also help prevent the breakdown in retina of the eye, 
which slows down macular degeneration and aids vision in the old age. The 
underlying mechanism is through the prevention of the breakdown of 
docosahexaenoic acid, which preserves vision in elderly people. 
Researchers found that sniffing the spicy aroma of cloves reduces 
drowsiness, irritability and headaches. One drop of clove oil applied to the 
roof of the mouth can instantly relieve many headaches. 
Clove enhances memory retention. It is recommended for relieving 
brain fog, lethargy and depressive state of mind. Research has shown that 
clove oil is an effective mosquito repellent. Clove may be looked upon as the 
champion of all the anti-oxidants known till date. The Oxygen Radical 
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Absorption Capacity test (ORAC) is a scale developed by U.S. Department of 
Agriculture for comparing antioxidantactivity. The ORAC score, of clove is 
over 10 million. A drop of clove oil is 400 times more powerful as an anti-
oxidant than wolf berries or blueberries. 
Review of literature showed lacunae exist in the pharmacognostic, 
phytochemical and pharmacological studies. The present study assesses the 
potential of S aromaticum in relation to its uses in epileptic seizure and in 
terms of findings on modern bio scientific research. 
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LITERATURE REVIEW 
 
TAXONOMICAL CLASSIFICATION 
(ITIS Report Taxonomic S.No 506167) 
Kingdom  : Plantae 
Sub Kingdom :           Viridiplantao 
Intra Kingdom : Streptophyta 
Super division : Empryophyta 
Division  : Tracheophyta 
Subdivision  : Spermatophytina 
Class   : Magnoliopsida 
Super order  : Rosanae 
Order   : Myrtales 
Family  : Myrtaceae 
Genus  : Syzygium 
Species  : aromaticum 
 
VERNACULAR NAME  
Common Name        :  Cloves, Carophyllus, Clovos, Caryophyllus 
Botanical Names    :  Eugenia caryophyllus, Syzygium aromaticum 
 
Names in Indian languages 
Sanskrit          :    Bhadrasriya, Devakusuma, Devapuspa,   
   Haricandana, Karampu, Lavanga, Lavangaka,  
   Lavangam, Varala.  
Hindi   :     Laung, Laumg, Lavang.  
CHAPTER II                                                                 LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI. Page 19 
Malayalam :    Grampu, Karampu, Karayampu.  
Marathi :    Luvang  
Kannada :    Lavanga, Daevakusuma, Krambu 
Tamil  :    Kirampu, Ilavankam, Kiraambu, Kirambu,Grambu. 
Telgu  :    Devakusumamu, Lavangamu, Lavangalu,  
   Kaaravallu 
Bengali :   Lavanga.  
Gujarati   :   Lavang   
Punjabi :   Laung  
Oriya  :   Labanga  
Urdu  :   Laung, Loung 
(Parle M &  Deepa K  2011) 
 
SYNONYM(S) :     
 Caryophyllus aromaticus 
 Eugenia caryophyllata 
 Eugenia caryophyllus 
 
HISTORY 
Archeologists have found cloves in a ceramic vessel in Syria, with evi-
dence that dates the find to within a few years of 1721 BC. In the third century 
BC, a Chinese leader in the Han Dynasty required those who addressed him 
to chew cloves to freshen their breath. Cloves were traded by Muslim sailors 
and merchants during the Middle Ages in the profitable Indian Ocean trade, 
the clove trade is also mentioned by Ibn Battuta and even famous Arabian 
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Nights characters such as Sinbad the Sailor are known to have bought and 
sold cloves from India.  
Until modern times, cloves grew only on a few islands in the Moluc-
cas (historically called the Spice Islands), including Bacan, Makian, Moti, Ter-
nate, and Tidore. In fact, the clove tree that experts believe is the oldest in the 
world, named Afo, is on Ternate. The tree is between 350 and 400 years 
old. Tourists are told that seedlings from this very tree were stolen by a 
Frenchman named Pierre Poivre in 1770, transferred to the Isle de 
France (Mauritius), and then later to Zanzibar, which was once the world's 
largest producer of cloves. 
Until cloves were grown outside of the Maluku Islands, they were 
traded like oil, with an enforced limit on exportation.As the Dutch East India 
Company consolidated its control of the spice trade in the 17th century, they 
sought to gain a monopoly in cloves as they had in nutmeg. However, "unlike 
nutmeg and mace, which were limited to the minute Bandas, clove trees grew 
all over the Moluccas, and the trade in cloves was way beyond the limited 
policing powers of the corporation. (Parle M & Deepa K 2011) 
 
ETHANO BOTANY DESCRIPTION 
         Syzygium aromaticum is a handsome evergreen tree that grows 30-40 
feet high, with extensive, branching, yellowish bark, leaves that are 4 inches 
long and 2 inches wide, rose-colored flowers (the rose color is said to be 
exquisite), and berry-like fruit. 
        The Clove itself consists of a dark-brown, solid, nearly cylindrical calyx, 
somewhat tapering below, and above divided into four ovate lobes; these 
lobes clasp the four lighter-colored arched and imbricate petals, which form a 
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globular head and cover the numerous bent stamens.  
The ovary is contained in the upper part of the adherent calyx, is 
divided into two cells, each containing about twenty ovules, and is crowned by 
a quadrangular disk, in the center of which the style is placed. 
Cloves are ½ to 2/3 inches long and as obtained from different 
localities, vary somewhat in the shade of their brown color. The large, plump 
and deep-brown cloves, as obtained from the Moluccas, Zanzibar, etc., are 
preferred. The smaller, shrivelled and light-colored varieties, such as are often 
exported from Cayenne and the West Indies being considered inferior. 
Cloves have a somewhat fatty appearance and a strong and highly 
aromatic odor, and a very pungent, warm and aromatic taste. A large number 
of oil-cells are observed in the petals and in the outer tissue of the calyx; the 
latter are placed in two or three irregular circles beneath the epidermis and 
yield some of their oil upon pressure with the fingernail.  
Cloves partly deprived of their volatile oil are said to be occasionally 
used for adulteration; they are quite moist and usually without the heads. The 
stalks, which are more pungent than the Cloves themselves, are either sold 
honestly or are sometimes used to adulterate ground Cloves (National 
Dispensatory, 1887)                                                                                           
 
BOTANICAL DESCRIPTION 
Syzygium aromatium tree is an evergreen tree, which grows to a height  
ranging from 8 – 12 m.Syzygium is a genus of flowering plant belongs to 
family myrtaceae.  The genus about 1200 – 1800 species.Large square leaves 
and sanguine flowers in numerous groups of terminal clusters.The flower buds 
are at first of pale color and gradually become green, after which they develop 
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into bright red.Cloves are harvested when 1.5 – 2cm long and consist of a 
long calyx, terminating in four spreading sepals and four unopened petals, 
which form a small ball in the centre. (Parle M &  Deepa K  2011) 
 
GEOGRAPHICAL DISTRIBUTION 
         Clove is commercially cultivated in India, Madagascar, Sri Lanka, 
Indonesia and the south of China. Now-a-days it also cultivated in Bangladesh 
in a small scale. (Bhuiyan N I et al .,2010). 
 
CLIMATE AND SOIL 
                 Clove trees grow well in rich loamy soils of the humid tropics and 
can be grown successfully in the red soils of the midlands of Kerala as well as 
in the hilly terrain of Western Ghats at higher elevations in Tamil Nadu and 
Karnataka. 
              A cooler climate with well distributed rainfall is ideal for flowering; it 
thrives well in areas receiving an annual rainfall of 150-300 cm. The site 
selected for cultivation of clove needs good drainage, since crop cannot 
withstand water logging .( Parle M &  Deepa K  2011). 
 
PROPAGATION: 
 Seed Propagation : The seed has a short viability of about 2 weeks so 
should be sown as soon as it is ripe in shady nursery beds, placing the seeds 
about 25mm deep in the soil. About 70% of the seeds germinate, usually after 
1 - 6 weeks]. Plant out when they are about 25cm tall. Cuttings of terminal 
leafy softwood, kept in a frame at high humidity until they have rooted. 
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HARVESTING AND PROCESSING 
The trees begin to flower in 6 years. Full bearing is achieved by about 
20 years and the production continues for 80 years or more. Bearing between 
years shows much variation. 
Clove clusters are handpicked, when the buds reach full size and turn 
pink but before they open. At this stage, they are less than 2 cm long. They 
are spread thinly on mats and stirred frequently for uniform drying. 
Well dried cloves will snap cleanly with a sharp click across the thumb 
nail and weigh about one third of the green weight. The opened flowers are 
not valued as a spice. Harvesting has to be done without damaging the 
branches, as it adversely affects the subsequent growth of the trees. 
On an average, a clove tree yields 3.5-7.0 kg/year, depending upon the 
age, size and condition of the tree (Parle M &  Deepa K  2011). 
 
WHOLE PLANT:- 
ETHANO MEDICINAL USES 
 Clove (Syzygium aromaticum)  is  some commonly used spices 
in households worldwide.(Shailesh 2015)  
 Clove is commonly used spices in the every Indian household 
for culinary purposes as well as in the treatment of various 
infections (Mittal M et al.,2014) 
 Syzygium aromaticum has also been used as remedy in herbal 
medicine. (Dehghani F et al.,2012) 
 It was reported that have been used in folk medicine as 
antimicrobial agents since ancient times .( Grayer, R.J. and J.B. 
Harborne, 1994, Cowan, M.M.,1999.) 
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 This plant has been used for centuries as food preservatives. 
( Mohammed KAK et al.,2016, Shan B et al.,2005) 
 Cloves are used in Indian ayurvedic medicine and Chinese 
medicine and Western her balism and dentistry. ( Khandelwal 
KJ et al.,2004) 
 This aromatic plant used as a carminative, to increase 
hydrochloric acid in stomach and to improve 
peristalsis.(Wankhede TB 2015, Khandelwal KJ et al.,2004) 
 In tropical Asia cloves have been given to treat such diverse 
infections as malaria, cholera and tuberculosis as well as 
scabies. (Bhowmik. D et al.,2012) 
 Traditionally cloves have been usedto treat flatulence, nausea 
and vomiting.( Tiwari P 2014) 
 Cloves are a natural anthelmintic. .(Ipsa Subhankari 2012, 
Nayak PL 2013 and  James  BP et al.,2000) 
 S. aromaticum plant to be used as a local antiseptic and 
anesthetic. ( Khandelwal KJ et al.,2004) 
 Clove is an anodyne (an agent that relives pain) for dental 
emergencies. (Shan B et al.,2005) 
 Applied to a cavity in a decayed tooth, it also relieves toothache. 
(Anderson L. et al.,2012) 
 Clove is used anti inflammatory agent. (Shan B et al.,2005) 
 Clove enhances memory retention.  It is recommended for 
relieving brain Fog, lethargy and depressive state of mind. 
(Shan B et al.,2005) 
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PHYTOCHEMISTRY: 
 Clove is one of the major vegetal sources of phenolic compounds such 
as flavonoids, hidroxibenzoic acids, hidroxicinamic acids and 
hidroxiphenyl propens. (Khalid A K  M et al.,2016) 
 Clove contain high content of Flavonoids. (Shan B et al.,2005) 
 The main bioactive compound of clove Eugenol is, which is found in 
concentrations ranging from 9 3 81.70 to 14 650.00 mg per 100 g of 
fresh plant material (Khalid A K  M et al.,2016) 
 The phenolic acids and gallic acid are the compounds found in higher 
concentration. However, other gallic acid derivates as hidrolizable 
tannins are present in higher  concentrations as compared with other 
compounds.(Shan B et al 2005) 
 
PHARMACOLOGY 
 It was reported that reduced levels of cytochrome P450 enzymes which 
specify the hepato-detoxification character of it. It also referred as 
vaso-relaxant effects. By considering all potent remedial properties, it 
also includes the anticancer properties.(Chowdhury M A R 2016). 
 As medicinal plants mainly as antioxidant agents and has antimicrobial 
activities. (Shan B et al.,2005) 
 
ANTIOXIDANT ACTIVITY 
 The aqueous extracts of clove have more antioxidant effect  tested by 
different  in vitro methods as 2,2-diphenyl-1-picrylhydrazyl (DPPH); 
2,2′-azino-bis (3-ethyl benzothiazoline-6-sulphonic acid) (ABTS), 
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oxygen radical absorbance capacity, ferric reducing antioxidant power, 
xanthine oxidase and 2-deoxiguanosine. (Dudonné S et al.,2009). 
 The in vitro antioxidant activity analysis by the ABTS method showed 
the higher antioxidant activity related with the polyphenols content. 
(Shan B et al.,2005). 
 
ANTIMICROBIAL ACTIVITIES: 
 The antimicrobial activities of clove have been proved against several 
bacteria and fungal strains. It was reported the antimicrobial activity of 
different Indian spice plant clove(Sofia P K et al.,2007) 
 The only sampled that showed complete bactericidal effect against all 
the food-borne pathogens tested Escherichia coli (E. 
coli), Staphylococcus aureus and Bacillus cereus was the aqueous 
extract of clove at 3%. At the concentration of 1% clove extract also 
showed good inhibitory action. (Sofia P K et al.,2007) 
 Clove  proved its enormous potential as food preservative among the 
other 30 plants analyzeddue to its antimicrobial aactivity( Dudonné S et 
al.,2009) 
 Recently, many reports confirmed the antibacterial, antifungal, antiviral 
and anticarcinogenic properties of this plant. Clove in particular has 
attracted the attention due to the potent antioxidant and antimicrobial 
activities standing out among the other spices (Shan B et al.,2005) 
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LEAF 
ETHANO MEDICAL USES : 
 This aromatic plant  leaves of clove used as a carminative, to increase 
hydrochloric acid in stomach and to improve peristalsis.(Wankhede TB 2015) 
 The leaves are used for antiseptic and antipyretic (Chaveerach A et al., 
2014). 
 
PHARMACOGNOSY 
 Leaves lanceolate, in pairs, acute at both ends 7.5 -12.3 cm , 2.5 -
3.75cm., gland-dotted, fragrant;  (Anonymous 1976 Wealth of india  
 These are simple, opposite ,coriaceous ,explitude, glbraous and 
aromatic.The Petiole is slender 2-3 cm long ,  swollen and  pinkish at 
the base and with the leaf blade partly decurrent upon it in the upper 
portion.The lamina is lanceolate or narrowly elliptically or obovate , the 
apex is shortly or broadly acuminate and the base is cuneate. 
(Anonymous 1976). 
 
LEAF OIL: 
ETHNOMEDICAL USES: 
 Traditionally clove leaf oil has been used to treat burns and cuts and 
even in dental care for alleviating toothache and infection.(Pulikottil S, 
Nath S  2015) 
 Traditional uses of clove leaf oil include use in dental care as an 
antiseptic and analgesic.(Razafimamonjison G 2005.) 
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PHARMACOGNOSY: 
 The yield of oil was 1.2% in 100 grams of clove  leaves. (Indu S , 
Ambujam N M L 2010, Utpala P et al.,2014) 
 It was reported that Clove leaves yield 3.0 – 4.8 % essential oil (Racing 
et al.,2001). 
 
PHYTOCHEMISTRY  
 It was reported that 38 components were identified in the leaf oil. The 
main components were eugenol (74.3%), eucalyptol (5.8%), 
caryophyllene (3.85%) and a-cadinol (2.43%) in leaf oil. (Bhuiyan N I et 
al .,2010). 
 The oil contained 94.4% eugenol followed by B – caryophyllene (2.9%), 
nerol (0.79%) and B-caryophyllene oxide (0.67%) (Raina VK et al 
2001). 
 The leaf oil of clove from Madagascar contained 22 constituents, the 
chief constituents being eugenol (82.0%) and B-caryophyllene (13.0%).  
It contained higher level of B caryophyllene compared with bud oil 
(7.2%) (Sriviastava AS et al.,2005) 
 A commercial sample of leaf oil obtained in Germany contained 76.8%. 
eugenol components. (Jirovetz L et al., 2006)    
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NEROL 
 
 
 Eugenol reached its Highest percentage in 
(i) Expanded leaves            =  84.00 – 90.48 % 
(ii)Mature leaves  = 88.32 – 90.22 % 
 Eugenyl Acetate reached its Highest percentage in  
Young leaves   = 61.44 – 65.52 % 
 Eugenol reached it Minimum percentage in 
(i) Young leaves   =     25.43 – 30.38 % 
(ii)Expanded leaves             =      58.29 – 61.53 % 
 Clove leaf oil contain various classes of compounds. (Eg) Monoterpenes, 
Sesquiterpenes aldetrudes and kotones (Vernin G et al.,1994.) 
 The yield of volatile oil was reported 3 – 4 %.  It was observed that 38.3 % to 
95.2%. Eugenol content variation in different development stage and at the 
sametime decrease of Eugenyacotic acid derivative and caryophylline.  The 
various classes of constituted are alldehydes, ketones and some classes of 
are aldehydes, ketones and some classes of terpines. (Vernin G et al.,1994.) 
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PHARMACOLOGY 
ANTIOXIDANT ACTIVITY 
 It was reported that the essential oil of clove leaf possess scavenging 
activity against DPPH radical at concentrations lower than the 
concentrations of Eugenol, BHT and BHA. It also shows a significant 
inhibitory effect against hydroxyl radicals and act as an  Iron 
chelator.(Gulein I et al., 2004 , Jirovetz L et al.,2006 ) 
 
BUD 
ETHNO MEDICAL USES 
 The clove has been used in India and China, for over 2,000 years, as a 
spice to check both tooth decay and counter halitosis ( bad breath ), 
mouth and throat inflammation.  (Bhowmik D et al,2012) 
 S.aromaticum, used most famously for toothache, and for mouth and 
throat inflammation.(Bhowmik. D et al.,2012) 
 Cloves have historically been used in Indian cuisine (both North Indian 
and South Indian). In the north Indian cuisine, it is used in almost every 
sauce or side dish made, mostly ground up along with other spices.  
(Bhowmik D et al.,2012)  
 Clove can be used to promote the flow of saliva and gastric juices. 
Clove can help to relieve the stomach pain or gas in the stomach and 
is used as an expectorant. (Bhowmik D et al,, 2012) 
 Cloves were taken over the centuries for diarrhea, most liver, stomach 
and bowel ailments, and as a stimulant for the nerves (Bhowmik D et 
al,2012,) 
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 Traditionally cloves have been used to treat flatulence, nausea and 
vomiting .In tropical Asia cloves have been given to treat such diverse 
infections as malaria, cholera and tuberculosis, as well as scabies( 
Bhowmik D et al ., 2012) 
 Taditional uses in America include treating worms, viruses, candida, 
various bacterial and protozoan infections ( Bhowmik D et al,2012) 
 Cloves became very popular as a medicinal flower, due to their ability 
to preserve foods, and mask the smell of poorly-kept foods.(Bullock 
and S. Harrison 2002) 
 Clove is used to help digestion, prevent vomiting in pregnancy and has 
inhibitory effect on histamine production.(Abozid MM, El-Sayet SM 
2013) 
 The buds are used for symptomatic relief of toothache and 
inflammation-pain in the mouth and throat as they are sources of anti-
microbial agents against oral bacteria commonly associated with dental 
caries and periodontal disease (Cai L  et al 1996) 
 This aromatic plant buds used as a carminative, to increase 
hydrochloric acid in stomach and to improve peristalsis.(Wankhede TB 
2015) 
 Along with the recreational uses of cloves, they are also said to be a 
natural anthelmintic. (Bhowmik D et al,2012) 
 Spices and herbs were originally added for improving taste and also 
can naturally and  safely improve shelf life of food products.(Maha M et 
al.,2012). 
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 Spices are also used for stabilizes in several food items from 
deterioration.(Jyothiprabha.V and Venkatachalam.P 2016) 
 It was reported that Ayurvedic system of medicine, the clove is 
popularly known for its aphrodisiac property and used to treat male 
sexual disorders. (Sharma A 2011). 
 It was reported  that the buds of clove were used in folk medicine as 
diuretic,stomachic, tonic for cardiac muscles,aromatic condiment 
properties and condiment with carminative and stimulant activity 
several compounds(Bhuiyan MD et al  2010) 
 
PHARMACOGNOSY  
Color  :  Deep brown, 
Odour  :  Powerful fragrant, intense fragrance 
Taste  :  Warm, pungent, strongly sweet and slightly astringent, 
   burning taste. 
 
PHYTOCHEMISTRY 
 It was reported that the presence of alkaloids in dichloromethane and 
aqueous extracts of clove(Shailesh,2015). 
 Antioxidant study and quantification of phenolic compound of  the 
extracts revealed that they have high antioxidant capacity. (Rahman 
Chowdhury M D A et al.,2016) 
 Total phenolic content of (SAf) as 407.69 mg/g equivalent of gallic acid, 
indicate potent phenolic content (Rahman Chowdhury M D A et 
al.,2016). 
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PHARMACOLOGICAL ACTIVITY 
 Clove extracts show high antifungal activity against Rhizoctonia solani 
(Lee S et al., 2003). 
 Clove in particular has attracted the attention due to the potent antioxidant 
and antimicrobial activities standing out among the other spices(Diego 
FCR et al.,2014) 
 Prolonged dose of S.aromaticum to swiss albino mice(8.35±2.07 and 
8.77±1.71mmol/L) having ablity to reduce blood glucose level by 
compared with the standard drug of vildagliptin (50 mg/kg).Hence  the 
methanolic extract of flower buds of Syzygium aromaticum (saf)  could be 
used in managing oxidative stress in  hyperglycemic condition. (Rahman 
Chowdhury M D A et al.,2016) 
 Syzygium aromaticum acts as anti-fungal ,anti-inflammatory anti-microbial 
, immunomodulator ,anti-carcinogenic, anti-mutagenic.(Dehghani F et 
al.,2012) 
 Antioxidant and estrogenic properties of Syzygium aromaticum may influence the 
sperm quality, sex hormones levels and the integrity of reproductive tissues. The 
present study was designed to verify the side effects of Syzygium aromaticum. 
Dehghani F et al.,2012) 
 The  high dose-treated animals showed a significant decline in sperm 
count, ( 250, 500 and 1000 mg/kg/day)  motility and testosterone but a 
significant increase in estradiol concentration compared with the control 
group.  The seminiferous tubules of extract-treated animals contained 
fewer sperms than in those of control animals. It seems that  aphrodiastic 
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activity of the S.aromaticum extract, it reduced spermatogenesis. 
(Dehghani F et al.,2012). 
 Clove offers neuroprotection against AlCl3-induced neurotoxicity.( Rami B 
Kassab, Amira A Bauomy, 2014) 
 Acute administration of an ethanolic extract of clove enhances the learning 
and memory recall processes in mice which support the anti-oxidative, 
anti-amyloid-β peptide activity and cholinomimetic action of its eugenol 
component.( Rami B Kassab, Amira A Bauomy, 2014) 
 Therapeutic properties of clove such as aphrodisiac, stomachic, 
carminative, antispasmodic, antiinflammatory,antioxidant, anti-
hyperglycemic, anti-stress, antimutagenic,and allelopathic as well as 
antiseptic and anesthetic to relieve toothache among other pains. It is also 
reported to be useful in conceiving in high doses and acts as a 
contraceptive in low doses and useful in cataract few studies about the 
effect of clove on the neuronal activities.( Rami B Kassab, Amira A 
Bauomy, 2014) 
 The clove has the ability to decrease the oxidative stress in diabetic rats ,it 
has ability to prevent diseases associated with oxidative stress.Moreover, 
eugenol and isoeugenol attenuated the levels of nitrite/nitrate, MDA and 
reactive oxygen species in acrylamide induced oxidative stress in rat’s 
brain .( Rami B Kassab, Amira A Bauomy, 2014)     
Hepato-protective activity  
It was reported that the ethanolic extract of Clove showed the 
hepatoprotective activity on  the  paracetamol-  induced  liver  injury.  The 
extent  of  hepatic  damage  is  assessed  by  the  level  of increased  
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cytoplasmic  enzymes  AST,  ALT  in circulation19 .    Clove  extract  restored  
the  activity  of enzymes AST, ALT and ALP in serum towards normal values. 
These enzymes assess the functional status of the liver in both clinical and 
experimental settings.  (Parle M &  Deepa K  2011) 
 
Anti-oxidant activity  
 In DPPH free radical scavenging assay found IC50 values  13.204 μg/ml, 
total antioxidant of SAf as 356.5 mg/g equivalent of ascorbic acid. 
%reducing power capacity (SAf)of as 239.79±.075( Rahman Chowdhury M 
D A et al.,2016) 
 Clove extract to diets already high in anti-inflammatory components (like 
cod liver oil, with its high ω-3 fatty acid content) brings a synergistic effect.( 
Parle M &  Deepa K  2011) 
 It was reported that Clove and Eugenol possess strong antioxidant activity 
than that of  the  synthetic antioxidant,  BHA  (butylated  hydroxyl  anisole)  
and Pyrogallol. (Parle M &  Deepa K  2011) 
 Clove has the highest capacity to give off hydrogen and reduce lipid 
peroxidation . With respect to the lipid peroxidation, the inhibitory activity of 
clove oil determined  using  a  linolenic  acid  emulsion  system indicated a 
higher antioxidant activity than the standard BHT  (Butylated  hydroxyl  
tolvene).(Parle M&  Deepa K  2011) 
 It  also  showed  a significant inhibitory effect against hydroxyl radicals and 
act as an  iron chelator . The  metal chelating  activity, bleomycin 
dependent DNA oxidation, diphenyl-p-picryl hydrazyl  (DPPH)  radical  
scavenging  activity  and  the ferric reducing antioxidant power (FRAP)  of 
different spices  were  measured  in rat  liver  homogenate. Cloves showed 
CHAPTER II                                                                 LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI. Page 37 
the highest DPPH radical scavenging activity & highest FRAP values. 
(Parle M & Deepa K  2011) 
 The antioxidant activity of clove bud extract and its major aroma 
components, eugenol and eugenol acetate were comparable to that of the 
natural antioxidant  α-tocopherol .  Eugenol  inhibited  5- lipoxygenase  
activity  and  leukotriene  C-4  in  human PMNL cells . (Parle M &  Deepa 
K  2011) 
Anti-platelet activity  
            It was found that both eugenol and acetyl eugenol, (two active  
constituents  of  clove)  were  more  potent  than aspirin  in  inhibiting  platelet  
aggregation  induced  by arachidonate,  adrenaline  and  collagen.  In  
arachidonate induced-aggregation  eugenol  was  at  par  with indomethacin. 
(Parle M &  Deepa K  2011) 
 
Anti-stress activity  
It was reported that the  clove  extract  reduced  the  development  of  
cold restraint  induced  gastric  ulcers  and  prevented  the biochemical  
changes  induced  by  sound  stress  such  as elevated  plasma  levels  of  
aspartate  aminotransferase, alanine  aminotransferase,  alkaline  
phosphtase,  glucose, cholesterol  and  corticosterone.  Clove  extract  was  
also effective  in  increasing  the  latency  of  anoxic  stress induced 
convulsions in mice. (Parle M & Deepa K 2011) 
 
Insecticidal activity  
It was reported that eugenol,  isoeugenol  and  methyl  eugenol  show 
insecticidal activity to the storage pathogens of  Sitophilu szeamis and 
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Tribolium costaneum. The clove  leaf and bud oils showed potent insecticidal 
activity against the human head louse (Pediculus capitis). (Parle M &  Deepa 
K  2011) 
 
HEPATO – PROTECTIVE  ACTION : 
 It was reported that ethanolic extract  of clove demonstrated the hepato 
protective action on the paracotomol induced liver damage.  The degree of 
hepatic harm is evaluated by the level of expanded cytoplasmic compounds.  
Clove concentrate restored the movement of compounds in serum towards 
ordinary qualities. (Parle M & Deepa K 2011) 
 
BUD OIL: 
ETHNOMEDICAL USES: 
 Aroma therapists use pure clove oil to cure the symptoms of 
rheumatism and arthritis.(Shan B et al.,2005) 
 The essential oil is used in aromatherapy .( Subhankari I and P.L. 
Nayak 2013) 
 Clove buds yield approximately 15 to 20% of a volatile oil that is 
responsible for the characteristic aroma and flavor.(Shama I.Y et al 
2013) 
 clove essential oil was possibly used as food preservative.( Hamad A, 
Hartanti D 2015). 
 Essential oil are used anodyne (painkiller) for dental purposes. (KJ 
Khandelwal et al.,2004) 
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PHYTOCHEMISTRY: 
 It was reported that the Good quality clove buds contains 15-20% 
essential oil.(Gopalakrishnan et al.,1988) 
 The volatile oil of cloves reported  that it contain 85-92% eugenol. 
(Debjit Bhowmik et al,2012). 
 It was reported that the oil from clove bud to contain 73.5-79.7% 
eugenol 4.5-10.7% Eugenol actate 7.3 – 12.4%.  β-caryophyllene and 
1.0 – 1.4%, humulene (Gaydou and Randriamiharison R 1987) 
 It was reported that the oil from Madagascar was richer in eugenol 
(82.6%) and Eugenyl acetate (6%) compared with that of India (70 and 
2.1% Respectively) Indian oil contained higher level of B – 
carryophyllene (19.5% against 7.2% in Madagascar oil) (Srivastava AS 
et al., 2005) 
 There is 36 compounds of the volatile oil of clove buds were identified.  
The major components of the bud oil were eugenol (69.8%),β–
caryophyllene (13%) and eugenyl acetate (16.1%) (Pino et al.,2001) 
 Thirty one components were identified in bud oil with the main 
components being eugenol (49.7%), caryophyllene (18.9%), 
benzene,1-ethyl-3-nitro (11.1%) and3-(1-methylethyl)  benzoic acid. 
(Bhuiyan N I et al .,2010). 
 It was reported that clove buds from India contained 12.9 – 18.5% oil of 
which 44 – 55% was Eugenol, the pedicels contained 3 – 7.7% oil with 
60 -72.4 % Eugenol. (Zachariah et al 2005). 
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 Wild uncultivated trees in Molucca yielded 3.0 -7.7 % bud oil.  The oil 
contained no eugenol and quite different from the bud oil from 
cultivated trees. (Guenther,1950). 
 The volatile oil of cloves reported  that it contain 85-92% eugenol.  
( Bhowmik D et al,2012). 
 Clove oil will stop the pain of a toothache when dropped into activity 
(Segacy EI.O et al 2007) 
 Concentrations up to 18% of essential oil can be found in the clove 
flower buds.(Jirovetz L et al.,2006) 
 Phenolic acids found in clove are the caffeic, ferulic, elagic and salicylic 
acids. Flavonoids as kaempferol, quercetin and its group (glycosilated) 
are also found in clove but in lower concentrations. 89% of the clove 
essential oil is eugenol and 5% to 15% is eugenol acetate and β-
cariophylline (Jirovetz L et al.,2006) 
 Another important compound found in the essential oil of clove in 
concentrations up to 2.1% is α-humulen.(Jirovetz L et al.,2006) 
 Other volatile compounds present in lower concentrations in clove 
essential oil are β-pinene, limonene, farnesol, benzaldehyde, 2-
heptanone and ethyl hexanoate. (Jirovetz L et al.,2006) 
 The sesquiterpenos B – caryophyllene, B – caryophyllene epoxide, - 
humulene epoxide and eugenol  (Zheng et al.,1992). 
 The chemical composition of S. aromaticum was also investigated. 
Phenylpropanoids such as carvacrol, thymol and cinnamaldehyde 
flavonoid triglycosides eugenol, eugenol acetate, caryophyllene, 
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sesquetrepene ester were found in S. aromaticum extract. (Dehghani 
F,2012)    
 The flower bud contains volatile oil (14% -21%), tannins(10% - 13%), 
phenol, sesquiterpenes, esters and alcohol. The most important 
constituent of clove is the phenylpropene, eugenol which gives this 
spice its pungent, distinctive aroma. .( Rami B Kassab, Amira A 
Bauomy, 2014) 
 Eugenol makes up 70 % to 90 % of the essential oil and 15 % of the 
  dry weight of clove buds.( Rami B Kassab, Amira A Bauomy, 2014) 
 
PHARMACOLOGICAL ACTIVITY: 
 One of the main constituents of clove oil (eugenol) exhibits broad 
antimicrobial activities against both Gram-positive, Gram-negative and 
acid-fact bacteria, as well as fungi . (Debjit Bhowmik et al,2012) 
 The volatile oil of cloves reported  that  was highly active against a 
range of test microorganisms, being classified as bactericidal in nature. 
(Debjit Bhowmik et al,2012) 
 
Anti-inflammatory activity  
It was reported that Eugenol, the primary component of clove’s volatile 
oils, functions  as  an  anti-inflammatory  agent.  Clove  also  contains  a  
variety  of  flavonoids,  including kaempferol,  rhamnetin and β-caryophyllene  
which also contributed to clove’s anti-inflammatory and antioxidant 
properties26 . The essential oil of Eugenia caryophyllata had  an  anti-
inflammatory  effect  matching  to  that  of etodolac  at  0.025  and  0.1  ml/kg  
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and  to  that  of indomethacin at 0.05 and 0.2 ml/kg doses. (Milind Pand  
Deepa K  2011)  
 
Mosquito repellent   
It was reported that  Clove oil gave the longest duration of 100% 
repellency (2-4 h) against three species of  mosquitoes  i.e.  Aedes aegypti,  
Culex  quinquefasciatus  and  Anopheles  dirus under laboratory conditions 
using human subjects. (Milind Pand  Deepa K  2011) 
 The oil also inhibits the growth of Fusarium verticilloides (Velutiet al., 
2004). 
 
Anti -viral activity  
 It was reported that Clove is a potent antiviral agent. Eugenin isolated from 
clove  buds  showed  antiviral  activity  against  Herpes Simplex virus at a 
concentration of 10 µg /ml16 . (Milind Pand  Deepa K  2011) 
 Essential oils from clove and eugenol showed various degree of inhibition, 
against A.niger, S. cerevisiae / mycoderma SP., Lactobacillus acidophilus 
and B. cereus as Estimated by the paper disc agar diffusion 
method.(Meena and sethi 1994). 
 Clove oil and eugenol are reported to possess significant antifungal activity 
against ryebread spoilage fungi (Suhr and Nielsen 2003). 
 Antiviral activity:Eugeniin  from  S.aromaticum  tested against herpes virus 
strains being effective at 5 μg/mL, and it was deducted that one of the 
major targets of eugeniin is the viral DNA synthesis by the inhibition of the 
viral DNA polymeras  (kurokawa M et al.,1998) 
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 clove oil showed potent anti-carcinogenic activity by inducing the 
detoxifying enzyme, glutathione –S– transferase in mouse liver and 
small intestine. (Zheng et al.,1992). 
 
Anti-microbial activity  
 Clove oil was found to be very effective againsStaphylococcus species 
and  fungi, Aspergillus  niger was  found  to  be  highly sensitive to the 
clove oil. (Milind Pand  Deepa K  2011) Clove oil was found to be more 
effective than sodium propionate (standard  food preservative)  against 
some food borne microbes. (Milind Pand  Deepa K  2011) 
 Essential oil of clove, dispersed (0.4%  v/v)  in  a  concentrated  sugar  
solution,  had  a germicidal  effect  against  various  bacteria  (S.  
Aureus, Klebsiella Pneumoniae, Pseudomonas aeruginosa, 
Clostridium perfringens, E.coli) and Candida albicans. (Parle M &  
Deepa K  2011) 
 Clove is also used for elimination of parasites from the digestive 
system. It has been found that a 0.05% solution of eugenol is sufficient 
to  kill  Bacillus  tuberculosis. (Parle M & Deepa K  2011) 
 Clove oil  showed antimicrobial  activity  against  some  human  
pathogenic bacteria resistant to certain antibiotics . (Parle M &  Deepa 
K  2011) 
 It also shows activity against clinically relevant fungi including 
fluconazole- resistant strains15. (Parle M &  Deepa K  2011) 
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Anti-pyretic effect: 
 Eugenol  was  more  effective  in  reducing fever  than  acetaminophen. 
. (Parle M&  Deepa K  2011) 
 It was reported that eugenol,  the  chief  constituent  of  clove  oil,  
showed marked  antipyretic  activity  when  given  intravenously, 
intragastrically and centrally to rabbits made febrile by interleukin-1.    It  
reduced  fever  primarily through  a  central  action  similar  to  that  of  
common antipyretic drugs, such as acetaminophen. (Parle M & Deepa 
K  2011) 
Anaesthetic effect : 
 It was reported that Clove oil is found to be an alternative to Tricaine or 
MS- 222  the  only  registered  anaesthetic  for  several  fish 
speciesand also used as crab anaesthetic,Clove  oil  at  the  
concentration  of  100mg/l  induced anesthesia  within  1min30 in  
channel catfish (Ictalurus punctatus) . 
 Clove  oil  and  eugenol  were reported  to  be  acceptable  
anaesthetics  for  rabbit  fish(Saiganus  lineatus),  coral  reef  fish  
(Pomacentrus amboinensis) and rainbow trout (Oncorhynchus 
mykiss)for  use  in  aqua  culture  and  aquatic  research .  
 Clove oil proved to  be  highly  effective  and  easy  to  use  on  juvenile 
Valamagugil  cunnesius  and  Monodactylus  argenteus) tropical 
marine fish at the dose of 0.05ml/l. This dose anaesthetized the fish in 
less than a minute. (Parle M & Deepa K  2011) 
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STEM 
PHARMACOGNOSY 
 Main stems erect. 100cm in girth, often forking at a height of 1.5 – 
1.8m. (Anonymous,1976) 
 
STEM OIL: 
PHARMACOGNOSY: 
 The yield of 5.5-7 % of volatile oil from stem has less pleasant odour 
than oil from buds (Anonymous,1976). 
 Clove stem yields 6% volatile oil (Gopalakrishnanet N  et al.1988) 
The oil is a pale yellow liquid (Gaydou  EM and  Harisoa  R 1987) 
 
PHYTOCHEMISTRY: 
 The oil generally contains a higher percentage of the free eugenol than 
the flower bud oils and only a small amount of eugenol 
acetate.(Anonymous,1976). 
 Stem oil from Madagascar contains 77.10% Eugenol and 11.20% B 
caryophyllene as the major compounds (Gaydou and Harisoa R 1987) 
 Stem oil used mainly in flavouring and perfumery and also to adulterate 
bud oil. .(Anonymous,1976). 
 
SEED 
PHARMACOGNOSY 
 Oblong, soft, grooved on one side, 1.5cm long. Seeds will not 
germinate if dried out fresh seeds should be planted soon after 
removal from from the fruit. 
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ROOT OIL: 
PHARMACOGNOSY: 
 It is obtained by steam distillation of the roots of clove tree. 
 The yield of oil from roots about 6 %, 
 Color: Bright yellow 
 
PHYTOCHEMISTRY: 
The oil of clove root contains 85-95%eugenol 
 
EUGENOL: 
 Eugenol, a methoxyphenol component of clove (Syzygium aromaticum, 
Family Myrtaceae), has been reported for a number of pharmacological 
effects, including the antioxidant, antiinflammatory, analgesic, 
anesthetic, antipyretic, antiplatelet, antianaphylactic, antidepressant, 
anticonvulsant, antihyperglycemic, antibacterial, antifungal and antiviral 
effects. The uses and benefits of eugenol isolated from various sources 
including Syzygium aromaticum and Ocimum sanctum are many.                                                                                                                                                                                             
 Eugenol and its derivatives in clove are potent antioxidants,  which 
could be due to their ability to form complexes with reduced metals; 
eugenol and structurally related compounds have been reported to 
inhibit iron-mediated lipid peroxidation and autooxidation of Fe2+ ion. 
Recently the effect of eugenol on hepatic glucose production and AMP-
activated kinase signaling in hepatocyte and C57BL/6J mice suggested 
eugenol or eugenol-containing fractions as promising therapeutic 
agent. In the study, eugenol effectively ameliorated hyperglycemia 
through inhibition of hepatic gluconeogenesis by modulating calcium 
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calmodulin dependent kinase kinase-AMP activated kinase-CREB 
binding protein signaling pathway.     
 In the liver, eugenol has been investigated for its antioxidant, 
antiinflammatory and DNA protective properties  The dried flower bud 
of Syzygium aromaticum is used in food for aroma, and in medicine for 
its carminative, antispasmodic, anticarcinogenic and other properties. It 
is known to inhibit platelet aggregation and alter arachidonic acid 
metabolism in human platelet, besides showing the antiviral activity 
against herpes simplex,  and antioxidant action in aflatoxicosis. The 
essential oil extracted from clove is used as topical application to 
relieve pain and promote healing.  
 Clove is a rich source of free eugenol, eugenol acetate, caryophyllene, 
sesquetrepene ester, phenylpropanoid and β-caryophyllene,besides 
tannins and triterpenoids.  It is used topically as analgesic in dental 
clinic and is antinociceptive, which might be due to α2-adrenergic and 
opioidergic receptors, but not serotonergic receptor.  Eugenol or 4-allyl-
2-methyoxyphenol (molecular weight: 164.20), the major constituent in 
clove, is an allyl chain-substituted guaiacol (2-methoxyphenol) which 
can also lower uric acid and is indicated in the treatment of rheumatoid 
arthritis.  
 It can induce apoptosis via the caspase-dependent pathway in human 
osteosarcoma cell. Eugenol is also known for its dose-dependent 
suppressive and enhancing effects on the immune response.  Clove oil 
and eugenol microemulsions have been found beneficial in fatty liver 
and dyslipidemia.  The formulation in microemulsion provides a 
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delivery system for oral administration of eugenol in homogeneous, 
water-based and thermodynamically stable dosage form. In CCl4-
induced hepatotoxicity in rats, eugenol protects liver injury when given 
concurrently or soon after the CCl4 treatment.  (Ali .S et al., 2014) 
 Dried flower bud of Syzygium aromaticum (clove) is rich in eugenol, an 
antioxidant and antiinflammatory compound that can protect liver 
against injury. Clove, besides eugenol, also contains other 
pharmacologically active phytochemicals such as β-sitosterol and 
ascorbic acid. This study reports the effect of eugenol-rich fraction 
(ERF) of clove on liver cirrhosis induced by thioacetamide.(Ali. S et al., 
2014) 
 
Drosophila Melanogaster AS MODEL ORGANISM 
This study reported that Drosophila has provided a powerful genetic 
system in which to elucidate fundamental cellular pathways, developing and 
functioning nervous system. Now a days, Drosophila has been applied toward 
elucidating mechanisms of human neurodegenerative disease, including 
Alzheimer's, Parkinson's and Huntington's diseases. Drosophila genome, 
underscore the contributions that Drosophila as a model genetic systems t 
and s to contribute toward the understanding of human neurodegenerative 
disease. (Chan H and Bonini NM, 2000). 
 
Drosophila MODEL ORGANISM FOR HUMAN 
NEURODEGENERATIVE DISEASE 
In this study reported that Drosophila melanogaster as a important 
model system in the study of human neurodegeneration. These studies offer 
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reliable models for Alzheimer’s, Parkinson’s, and motor neuron diseases, as 
well as models for trinucleotide repeat expansion diseases, including ataxias 
and Huntington’s disease, several signalling pathways including 
phosphatidylinositol 3-kinase (PI3K)/Akt and target of rapamycin (TOR), c-Jun 
N-terminal kinase (JNK) and bone morphogenetic protein (BMP) signalling, 
have been shown to be deregulated in models of proteinopathies, suggesting 
that 2 or more initiating events may trigger disease formation in an age-
related manner. Moreover, these studies also demonstrate that the fruit fly 
can be used to screen chemical compounds for their potential to prevent or 
ameliorate the disease, can directly guide clinical research and the 
development of novel therapeutic strategies for the treatment of human 
neurodegenerative diseases. (Hirth F 2010). 
 
ALZHEIMER'S DISEASE 
In this study reported that Alzheimer's disease (AD) is most 
common degenerative brain diseases, affecting 11% of over 65 years of age 
and 50% over the age of 85 population. Alzheimer's disease (AD) disease 
brain tissue displays several unique pathological including senile neuritic 
plaques and neurofibrillary tangles. Senile neuritic plaques are extracellular 
deposits consisting of b-amyloid peptides, while neurofibrillary tangles are 
cytoplasmic aggregates composed of the paired helical filaments of hyper 
phosphorylated.These abnormal deposits form primarily in brain regions that 
are essential for cognition and memory, with Alzheimer's disease (AD) 
patients typified by dementia. . (Chan H and Bonini NM, 2000) 
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MODEL ORGANISM FOR ALZHEIMER DISEASE 
In this study was suggested that Most of the genes implicated in AD 
pathogenesis have clear fly homologs. There is a fly homolog of APP (APP-
like or APPL). Flies deficient for APPL exhibit a behavioural abnormality that 
can be rescued by a human APP transgene, indicating functional 
conservation between APPL and human APP. It is possible that other 
proteases may provide a similar function, as it has been reported that 
overexpression of human APP causes axonal transport defects and increases 
cell death in the larval brain in an Aβ-dependent manner. Some one study 
showed that Aβ peptide can be generated in Drosophila from a modified 
human APP transgene. (Lu B and Vogel H., 2009). 
 
PARKINSON’S DISEASE  
In this study reported that Parkinson’s Disease (PD) is the most 
common movement disorder and the second most common 
neurodegenerative disease. The classical form of the disease is clinically 
characterized by muscle rigidity, resting tremor, bradykinesia, and postural 
instability. The movement abnormality in Parkinson’s Disease (PD) is largely 
attributable to the deficiency of brain dopamine content, which is caused by 
degeneration of dopaminergic neurons in the substantia nigra. The most 
common forms of PD are sporadic with no known cause.(Lu B and Vogel H., 
2009). 
 
MODELING PARKINSON’S DISEASE IN Drosophila 
In this study showed α-Syn in Drosophila has reproduced key features 
of Parkinson’s Disease (PD), including Lewy body–like aggregate formation, 
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selective degeneration of dopaminergic neurons, and loco motor behaviour 
abnormality as detected by climbing ability in the negative geotaxis response. 
The fact that both mutant and wild-type α-Syn form aggregates in fly neurons 
and cause disease phenotypes supports the notion that improper disposal of 
aggregation-prone abnormal proteins can result in neurodegeneration. This is 
also consistent with the finding that genomic triplication of α-Syn in humans 
can cause Parkinson’s disease (PD). Important two prominent features of 
parkin-mutant flies are mitochondrial pathology and apoptotic muscle 
degeneration. These mutant flies’ exhibit sterility, reduced lifespan, reduced 
cell number and size, and hypersensitivity to oxidative stress. (Lu B and Vogel 
H., 2009). 
 
IDENTIFYING SPOTTED WING Drosophila 
In this study reported that Adult Spotted Wing Drosophila are 2-3 mm 
long, have rounded abdomens. Flies are light yellow or brown with red eyes. 
Dark unbroken bands are seen across the abdominal segments. 
Distinguishing characteristic is that the adult male Spotted  
Wing Drosophila (SWD) has one distinctive dot on each of its wings 
along the 1st vein. Male Spotted Wing Drosophila (SWD) also have two dark 
bands on each of the forelegs. In these bands are known as combs and 
contain three to six teeth. Female Spotted Wing Drosophila (SWD) are harder 
to identify, as they do not have these wing spots. Female Spotted Wing 
Drosophila (SWD) have serrated ovipositors with two rows of serration that 
are longer than other vinegar fly species. (Timmeren SV, O’Donnell K et 
al.,2012) 
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HUNTINGTON DISEASE 
In this study reported that Huntington disease (HD) is caused by a 
polyglutamine expansion mutation in huntingtin (HTT) that makes the protein 
toxic and aggregate-prone. The subcellular localisation of huntingtin and 
many of its interactors suggest a role in endocytosis, and recently it has been 
shown that huntingtin interacts indirectly with the early endosomal protein 
Rab5 through HAP40. (Ravikumar B, Imarisio S et al., 2008). 
 
  
AIM AND 
OBJECTIVE 
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AIM AND OBJECTIVE 
 
Volatile oils (V.O) are valuable natural products find applications in 
many area, including pharmaceuticals, cosmetics, perfumes, aromatherapy, 
phytotheraphy, spices etc. Attention of many scientists was attracted towards 
the screening of plants to study the biological activities of their oils from 
phytochemical and pharmacological to therapeutic aspects. This may be 
hopefully lead to new directions on plant applications and new perspectives 
on the potential therapeutic use of these natural products. VO are complex 
mixtures comprising many single compounds. The knowledge of its 
composition permits for a better and specially directed application. 
Essential oils consist of monoterpenes and sesquiterpenes which are 
the lipophilic secondary metabolites of plants Various organic components are 
identified when essential oils are analyzed with a GC chromatograph which 
are as follows Terpene hydrocarbons (Monoterpene hydrocarbon,  
sesquiterpines), Oxygenated compounds (phenols, Alcohol,) Aldehyde, 
Ketones, Esters, Lactones, Coumarins, Ethers 
 
ALZHEIMER’S DISEASE 
Alzheimer’s disease patient’s exhibits marked decline in cognitive 
functions and severe behavioral abnormalities such as irritability, aphasia, 
apraxia, agnosia and restlessness. Neuritic plaques a core of β-amyloid 
aggregates covered by dead neurons, microglia and apolipoprotein E and 
neurofibrillary tangles are the major pathological lesions and neuronal death 
of an Alzheimer brain.   
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 Dementia is failing memory and other intellectual function with little or 
on no disturbance in consciousness.β-amyloidal (Aβ) deposition is 
pathognenic for Alzheimer’s disease (AD), but may occur in normal elderly 
people without apparent cognitive effect. Episodic memory impairment is an 
early and prominent sign of AD, but its relationship with Aβ burden in non-
demented persons and in AD patient is unclear.   
 Cognitive deficits have long  been recognized as severe and consistent 
neurological disorders associated with numerous psychiatric and 
neurodegenerative disease, such as AD, senile dementia, Parkinson’s 
disease, Huntington’s disease, korsakoff’s syndrome, down’s syndrome, 
pick’s disease, trauma, chronic insomnia, epileptic disorder and attention 
deficit disorders. 
            The personality distortions interfere with the patient’s professional life, 
social activities and relationships. Nootropic agent such as piracetam, 
aniracetam and choline esterase inhibitors like Donepezil® are being primarily 
used to improve memory, mood and behavior, but the resulting side effects 
associated with these agents have made their use limited.  
 
NEED FOR THE STUDY 
AD is a progressive brain disorder that gradually destroys a person’s 
memory and ability to learn, reason, make judgment, communicate and carry 
out daily activities and ultimately leads to death. They are the most common 
form of dementia, a group of conditions that all gradually destroy brain cells 
and lead to progressive decline in mental function. The prevalence of mental 
and cognitive disorders, referred to as cognitive deficits which impinge on 
daily life and are thus of consequence to both those affected and society 
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doubles every five years between the ages of 60 and 95. Epidemiological 
studies have revealed that between two-thirds and Alzheimer’s disease 
entirely or significantly causes three quarters of all cognitive deficits. 
Modulation of brain aging with complex extracts containing active 
photochemical has been useful in the aging of wild type rodents with 
encouraging results. Ayurvedic medicinal plants had successfully attenuated 
memory dysfunction induced by scopolamine, ethanol and diazepam. Recent 
advancements in the treatment of Alzheimer’s disease and controlled studies 
have demonstrated that cholinesterase inhibitors delay cognitive decline by 6-
10 months. Three AchE- inhibitors agents are available in Switzerland: 
tacrine, Donepezil and Rivastigmine. Tacrine is first generation AchE- 
inhibitors. Donepezil and Rivastigmine are second generation AChE- 
inhibitors, which are selectively centrally active. Despite of their relatively 
selective and central action, second generation AchE- inhibitors may still 
cause dose dependent cholinergic adverse effects. Thus the treatment of 
Alzheimer’s disease has become a demanding interdisciplinary 
undertaking.Normal aging is known to deteriorate memory in human beings. 
Oxygen free radicals, the harmful by products of oxidative metabolism are 
known to cause organic damage to the living system, which may be 
responsible for the development of AD in elderly.    The present study has 
been designed to investigate the nootropic potential of VO, a major 
phytochemical present in various speciesof the Myrtaceae family. 
Encapsulation of bioactive compounds represents a feasible and 
efficient approach to modulate drug release, increase the physical stability  of 
the active substances, protect them from the interactions with the 
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environment, decrease their volatility, enhance their bioactivity, reduce 
toxicity, and A significantly large part of current literature on the encapsulation 
of EOs deals with micrometric size capsules, which are used for the protection 
of the active compounds against environmental factors (e.g., oxygen, light, 
moisture, and pH),to decrease oil volatility and to transform the oil into a 
powder. Encapsulation in nanometric particles is an alternative for overcoming 
these problems but additionally, due to the subcellular size, may increase the 
cellular absorption mechanisms and increasing bio efficacy improve patient 
compliance and convenience. 
Eos have promising potentials for maintaining and promoting health, as 
well as preventing and potentially treating some diseases. However, the 
generally low water solubility and stability, together with the high volatility and 
side effects associated with their use have limited their application in 
medicine. Nanotechnology is an innovative approach that has potential 
applications in medicinal and health research. Indeed, nanoparticles are a 
very attractive tool and are able to solve the major inconvenience of EOs use 
increasing the chemical stability in the presence of air, light, moisture and, 
high temperatures, factors which can lead to the rapid evaporation and to the 
degradation of the active components. In addition, nanocarriers ensure the 
easier and safer handling of the liquid substances by changing them in solid 
powders, determining retention of volatile ingredients and taste masking, 
setting up controlled release and/or consecutive delivery of multiple active 
ingredients, reducing toxic side effects, improving water solubility of 
hydrophobic ingredients, and enhancing bioavailability and efficacy. 
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AIM: 
To study the pharmacognostic, preliminary phytochemical screening of 
the leaves of Syzygium aromaticum (L.) Merril & Perry Fam: Myrtaceae and 
also to investigate the in vivo neuroprotective effects of the nanospheres of 
the leaf volatile oil (SALVONS) on β amyloid  induced neuro degeneration in 
transgenic Drosophila. 
  
OBJECTIVE  
The objective of the study was divided into three parts. 
 
PART 1: PHARMACOGNOSTICAL STUDY 
 Collection and authentication of plant 
 Morphological study of the plant 
 Microscopy of the leaf 
 Anatomical study using light microscope 
 SEM analysis 
 Powder microscopy 
 Microscopic schedules 
 Physio-chemical parameters 
 Ash values 
 Loss on drying 
 Extractive values 
 
PART 2: PRELIMINARY PHYTOCHEMICAL SCREENING 
 Qualitative analysis of the leaves for the presence of various phyto 
constituents 
 Determination of flavonoid content, total phenolic content of the leaf,  
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 Determination trace elements by SEM 
 Isolation of volatile oil from the leaves (VOSAL) 
 Physico- chemical analysis of the isolated oil 
 To study the GC-MS profile of the isolated VO 
 Preparation of nano spheres of the VO (SALVONS) 
 Characterisation of the prepared nanospheres 
 
PART 3: PHARMACOLOGICAL STUDIES: 
 The 3R’s ethical principle (Reduction, Refinement, and Replacement) 
was implemented that help to minimize harms to vertebrate animals used in 
science.  
 Acute toxicological study using brine shrimp lethality bioassay(BSLA) 
 Production of Artemia nauplii 
 Cytotoxicity bioassay 
 Lethality concentration determination 
 Effect on Mutagenesis of VOSAL on Drosophila melanogaster In vivo 
effect of the SALVONS ofon the transgenic Drosophila melanogaster with  
Aβ 42  induced  neuro degeneration 
 Preparation of medium for cultivation of Drosophilla melanogaster. 
  Cultivation of  normal and  transgenic Drosophilla melanogaster model 
that over express human Aβ42 resulted in reduced lifespan, reduced 
locomotor activity and eye degeneration 
 Effect of  SALVONS on longevity of Aβ42 expressing  Drosophila 
 Effect of SALVONS on locomotor function by climbing assay of Aβ42 
expressing  Drosophila 
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 To perform Pseudopupil assay to determine rescued neuro 
degeneration in ommatidia of Aβ42 expressing  Drosophila 
 To examine the external morphology of the Drosophila eyes by nail 
polish imprint technique to examine any disruption in the ordered 
arrays of the ommatidia 
 To study the morphology of the Drosophilaseye using SEM to examine 
any disruption in the ordered arrays of the ommatidia 
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MATERIALS AND METHODS 
RESEARCH DESIGN 
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MATERIALS AND METHODS 
 
4.1. PLANT COLLECTION AND AUTHENTICATION: 
Leaves of the plant Syzygiumaromaticumselected for our study was 
collected from Halieyberiyar estate, Idukki District, Kerala, India during the 
month of July 2017 and was authenticated by Dr.Stephen, Department of 
Botany, American college, Madurai and Dr.Sasikala, Director (Retd) of 
Siddha Central Research Institute, Arumbakkam, Chennai. 
 
LEAF DRYING AND PULVERIZING: 
The leaves were collected and shade dried. It was powdered in a 
mixer. The powder was sieved in a No.60 sieve and kept in a well closed 
container in a dry place. 
  
4.2. PHARMACOGNOSTICAL STUDIES: 
Morphological and micro morphological examination and 
characterization of medicinal plants have always been accorded due 
credentials in the pharmacognostical studies. Botanical identity of the plants is 
an essential prerequisite for undertaking the analysis of medicinal properties 
of any plant. A researcher may succeed in getting a new compound or may 
find many useful pharmacological active properties in the plant. If the 
botanical identity of the plant happens to be dubious or erratic, the entire work 
on the plant becomes invalid. Thus it is needless to stress the botanical 
identity of the crude drug is the threshold in the processes of pharmacological 
investigations. The researchers should be equipped with all possible 
diagnostic parameters of the plant on which the researchers plan to work. 
 
CHAPTER IV                                                     MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY,COP, MMC, MADURAI      Page 62  
4.2.1. MORPHOLOGICAL STUDIES OF Syzygium aromaticum 
Aerial part, leaf and petiole, flower, fruits and root were studied 
individually for its morphological characters by organoleptic test. 
 
4.2.2. MICROSCOPICAL STUDIES ON THE LEAF OF 
Syzygiumaromaticum 
COLLECTION OF SPECIMEN: 
Care was taken to select healthy plants and for normal organs. Leaf, 
Petiole specimens were collected from a healthy plant by making a cut with 
petioles.The materials were cut into pieces and immediately immersed in 
fixative fluid FAA (Formalin – 5ml + Acetic acid – 5ml +70% Ethyl alcohol – 
90ml).  
 
DEHYDRATION: 
After 24 hours of fixing , the specimens were dehydrated with graded 
series of  ethyl alcohol and tertiary-butyl alcohol (Sass, 1940). The specimen 
is kept is in each grade of the fluid for about 6 hrs.Every time the fluid is 
decanted and immediately the specimen were flooded with next grade of fluid.  
 
INFILTRATION WITH PARAFFIN WAX: 
After dehydration, the shavings of paraffin wax were added to the vial 
containing the plant  material with pure TBA. The paraffin shavings are added 
every 30mts at about 40-45ºC four or five times. Then the vials were filled with 
wax without damaging the tissues. The vial filled with wax is kept open in 
warm condition to evaporate all TBA, leaving the specimen in pure molten 
wax. The specimen filled with pure molten wax for  2 or 3 times by decanting 
the old wax every time. 
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CASTING TO MOLD: 
A boat made out of chart board, by folding the margin, is used to 
prepare a mold of wax containing specimens. The paraffin along with the leaf 
and petiole specimen was poured into the boat. With the help of heated 
needles, the specimen were arranged  in parallel rows with enough space in 
between the specimens. The block was then immersed in chilled water and 
allowed to cool for few hours. 
 
SECTIONING: 
The paraffin embedded specimens were sectioned with the help of 
microtome. The thickness of the sections was 10-12μm. Dewaxing of the 
sections was by customary procedure. The sections were stained with 
Toluidine blue as per the method published by O’Brien et al (1964). Since 
toluidine blue is a poly chromatic strain, the straining results were remarkably 
good  and some cytochemical reactions were also obtained. The dye 
rendered pink colour to the cellulose walls, blue to the lignified cells, dark 
green to suberin, violet to the mucilage, blue to the protein bodies etc. 
Where ever necessary sections were also stained with safranin and fast-
green and  potassium iodide (for starch ). For studying the stomatal 
morphology, venation patttern and trichome distribution, paradermal 
sections (sections taken parallel to the surface of leaf as well as clearing of 
leaf with 5% sodium hydroxide or epidermal peeling by partial maceration 
employing Jeffrey’s maceration fluid (Sass, 1940) were prepared. Glycerin 
mounted temporary preparations were made for macerated/cleared materials. 
Powdered materials of differentparts were cleared with sodium hydroxide and 
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mounted in glycerin medium after staining. Different cell components were 
studied and measured. 
 
PHOTOMICROGRAPHS: 
Microscopic descriptions of tissues are supplemented with micrographs 
wherever necessary. Photographs of different magnifications were taken.with 
Nikon labphot 2 Microscopic unit. For normal observations bright field was 
used. For the study of crystals, starch grains and lignified cells, polarized light 
were employed. Since these structures have birefringent property, under 
polarized light they appear bright against dark background. Magnifigations of 
the figures are indicated by the scalebars. (Johansen DA, 1940, Purvis MJ et 
al., 1966). 
 
4.2.3. MICROSCOPICAL STUDY OF LEAF USING SCANNING ELECTRON 
MICROSCOPE: 
SCANNING ELECTRON MICROSCOPE (SEM): 
Movement of beam of foccussed electrons across an object forms a 3D 
image on a cathode - ray tube in a Scanning Eectron Microscope and it reads 
both the electrons scattered by the object and the secondary electrons 
produced by it. The electromagnetic lenses are used in SEM and focussing is 
done by the current. On photographic plate of screen the image is projected 
which gives comprehensive, quasi 3-D representation of the objects gives the  
ultra structure of plant cells. In addition , shows the unsuspected details and 
any undescribed characters. In other words the micrograph from SEM, shows 
the best possible structural details of the specimens.  (Robards, 1970) 
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USAGE: 
SEM info was handled as conventional character (or) character 
complexes as “pure” information without being broken down (or) interpreted  
as individual character using computer processing. The SEM information can 
be used some what at the superficial level just described to assist in solving 
taxonomic problem by confirming, changing (or) other grounds. It is also used 
often as diagnostic feature to avoid misleading by over simplified descriptions 
and one may find new kinds of microstructures not previously recognised and 
apprently simple structures may be extremely complex. Remarkably, poor 
conventional descriptions enabling taxonomic process of reducing a complex 
pattern to a few simple characters (Heywood VH, 1971).SEM plays a vital role 
when a specimen need to be satisfactorily defined in terms of characters. For 
most biological materials, maximum information is obtained by employing  
light and electron microscopy jointly and an attempt was made by applying 
SEM to the leaf of S.torvum, to pinpoint the positions of specific characters 
with in the cell, which can be easily seen in final image. 
 
SEM SAMPLE PREPARATION: 
Sample for SEM analysis were mounted on the specimen stub using 
carbon adhesive sheet. Small sample were mounted with  I sq. cm  glass slide 
and kept in carbon adhesive sheet.. Samples were coated with gold to a 
thickness of 100 AO using hitachi vacuum evaporator. Coated sample were 
analysed in a Hitachi  Scanning electron Microscope 3000 H model. 
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4.2.4. POWDER MICROSCOPY: 
MACERATION TECHNIQUE: 
Maceration is the process of separation of individual cells by selectively 
dissolving the pectic middle lamella between the cells. The middle lamella 
binds the cells with each other forming different tissues. The middle lamella is 
dissolved by employing a chemical that dissolves the lamella to free the cells 
to obtain their three dimensional view. 
 
MACERATION FLUID: 
Jaffrey’s maceration fluid is one that is commonly used for maceration 
(Johnsen DA, 1940). The fluid consists of equal volumes of 5% chromic acid 
and 5% nitric acid. The plant material is cut into small pieces and immersed in 
the maceration fluid. The fluid with the materials is kept at 55ºC for 3-5 hrs. 
Then the material is washed thoroughly with water and placed on a glass slide 
in a drop of Safranin (0.5%) for 15-20 min. The stain is drained carefully and 
mounted with a drop of dilute glycerine. The cells are spread well with a 
needle and the material is covered with cover slip. The slide so prepared is 
examined under the microscope to study different components of the 
macerate. 
 
4.2.5. MICROSCOPIC SCHEDULES: (Wallis TE. 1953, Wallis TE, 1965, 
Iyengar MA, 1994, Anonymous, 2001) 
The vein islet number, vein terminal number, stomatal number and 
stomatal index were determined on fresh leaves using standard procedures. 
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A. VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER: 
The term vein islet in used to denote the minute area of photosynthetic 
tissue encircled by the ultimate divisions of the conducting strands. The 
number of vein islets per sq.mm. Area is called vein islet number. 
Vein terminal number may be defined as the number of vein terminals 
present in one sq., mm. area of the photosynthetic tissue. 
 
B. DETERMINATION OF VEIN ISLET NUMBER AND VEIN TERMINATION 
NUMBER: 
Small square portion from the lamina region of the leaf was cleared in 
chloral hydrate, stained and mounted on a slide. A camera Lucida is set up 
and by means of a stage micro meter the paper is divided into squares of 
1mm2using a 16mm objective.  The stage micro meter is then replaced by the 
cleared preparation and the veins are raced in four continuous squares, either 
in a square 2mm x 2mm (or) rectangle 1mm x 4 mm. 
When counting, it is convenient to number each vein-islet on the 
tracing. Each numbered area must be completely enclosed by veins, and 
those which are incomplete are excluded from the count if cut by the top and 
left-hand sides of the square (or) rectangle but included if cut by the other two 
sides. Ten readings for vein islet and vein termination number were recorded.  
 
C. STOMATAL INDEX: 
It is the percentage, which the numbers of stomata from the total 
number of epidermal cells, each stoma being counted as one cell. 
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I. Stomatal index  = S/S+E x 100 
Where,         S = Number of stomata per unit area 
E = Number of epidermal cells in the same unit area 
 
D. DETERMINATION OF STOMATAL INDEX: 
The procedure adopted in the determinations of stomatal number was 
observed under high power (45 X).The epidermal cells and the stomata were 
counted. From these values the stomatal index was calculated using the 
above formula.  
 
4.2.6 PHYSICOCHEMICAL PARAMETERS: (Anonymous, 1996, 1998, 2001) 
DETERMINATION OF ASH VALUES: 
ASH VALUE: 
The ash values were determined by using air dried powder of the leaf 
as per the official method. 
 
TOTAL ASH: 
Two grams of the air dried leaf powder was accurately weighed in a 
silica crucible separately.  The powder was scattered into a fine even layer on 
the bottom of the crucible and incinerated by gradually increasing the 
temperature not exceeding 450oc, until free from carbon.  Then it was cooled 
and weighed for constant weight.  The percentage of ash with reference to the 
air dried powder was calculated. 
 
WATER SOLUBLE ASH: 
The ash obtained from the total ash procedure was boiled with 25ml of 
water for 5 minutes and the insoluble matter was collected on an ash less 
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filter paper and washed with hot water.  Then it was ignited for 15 minutes at a 
temperature not exceeding 450oc.  The weight of the insoluble matter was 
subtracted from the weight of the total ash. The difference in weight 
represents the water soluble ash. The percentage of water soluble ash was 
calculated with reference to the air dried powder. 
 
ACID INSOLUBLE ASH: 
The ash obtained from the total ash was boiled for five minutes with 
25ml of dilute hydrochloric acid.  The insoluble matter was collected in a 
tarred sintered glass crucible.  The residue was washed with hot water, dried 
and weighed.  The percentage of acid insoluble ash with reference to the air 
dried drug was calculated.  
 
DETERMINATION OF LOSS ON DRYING 
For the determination of loss on drying, the method described by Wallis 
was followed. One gram of dried powdered leaf was accurately weighed in a 
tarred Petri dish, previously dried under the conditions specified in IP’96. The 
powder was distributed as evenly as practicable, by gentle sidewise shaking.  
The dish was dried in an oven at 100 – 105°C for 1 hour.  It was cooled in 
desiccators and again weighed.  The loss on drying was calculated with 
reference to the amount of the dried powder taken. 
 
EXTRACTIVE VALUES  
PETROLEUM ETHER SOLUBLE EXTRACTIVE VALUE 
 Five gram of the coarsely powder was macerated separately with 
100ml of petroleum ether in a closed flask for 24 hrs.  It was frequently 
shaken for the first 6 hours and allowed to stand for 18 hours. Thereafter it 
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was filtered rapidly taking precaution against loss of petroleum ether. 25ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, 
dried at 105oC and weighed. The percentage of the petroleum ether soluble 
extractive value was calculated with reference to the air dried powder. 
 
ETHANOL SOLUBLE EXTRACTIVE VALUE 
Five gram of the coarsely powder was macerated separately with 
100ml of ethanol in a closed flask for 24 hrs.  It was frequently shaken for the 
first 6 hours and allowed to stand for 18 hours. Thereafter it was filtered 
rapidly taking precaution against loss of ethanol.  25ml of the filtrate was 
evaporated to dryness in a tarred flat bottomed shallow dish, dried at 105oC 
and weighed. The percentage of the ethanol soluble extractive value was 
calculated with reference to the air dried powder. 
 
WATER SOLUBLE EXTRACTIVE VALUE: 
Five gram of the coarsely powder was macerated separately with 
100ml of chloroform water in a closed flask for 24 hrs.  It was frequently 
shaken for the first 6 hours and allowed to stand for 18 hours. Thereafter it 
was filtered rapidly taking precaution against loss of chloroform water. 25ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, 
dried at 105oC and weighed. The percentage of the chloroform water soluble 
extractive value was calculated with reference to the air dried powder. 
 
4.3 PHYTOCHEMICAL STUDIES:  
[Anonymous, 1998, Chaudhri RD, 1999, Kokate CK, 2005, Agarwal, 
2007, Horbone JB, 1973]. 
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4.3.1 PRELIMINARY PHYTOCHEMICAL SCREENING:  
TEST FOR ALKALOIDS: 
VARIOUS PROCEDURES TO LIBERATE ALKALOIDS: 
 Powdered drug was mixed thoroughly with 1ml of 10% ammonia 
solution and then extracted for 10 minutes with 5 ml methanol, under 
reflux.  The filtrate was then concentrated. 
 Powdered drug was mixed thoroughly with 1ml of 10% sodium 
carbonate solution and then extracted for 10 minutes with 5ml 
methanol, under reflux.  The filtrate was then concentrated. 
 Powdered drug was ground in a mortar for about 1 minute with 2ml 
of 10% ammonia solution and then thoroughly mixed with 7 gram 
basic Aluminium oxide.  The mixture was then loosely packed into a 
glass column and 10ml chloroform was added, eluted, dried and 
methanol was added. 
 Powdered drug was shaken for 15 minutes with 15ml of 0.1 N 
sulphuric acid and then filtered.  The filter was washed with 0.1 N 
sulphuric acid to a volume of 20ml filtrate; 1ml concentrated 
ammonia was then added.  The mixture was then shaken with two 
portions of 10ml diethyl ether.  The ether was dried over anhydrous 
sodium  
 Sulphate, filtered and evaporated to dryness and the resulting 
residue was dissolved in methanol. 
 Powdered drug was mixed with one gram of calcium hydroxide and 
5ml of water, made into a smooth paste and set aside for 5 minutes.  
It was then evaporated to dryness in a porcelain dish on a water 
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bath.  20ml of 90% alcohol was added, mixed well and then refluxed 
for half an hour on a water bath.  It was then filtered and the alcohol 
was evaporated.  To that dilute sulphuric acid was added. 
 The above made extracts were tested with various alkaloid reagents 
as follows. 
 
1. MAYER’S REAGENT 
2. DRAGENDORFF’S REAGENT 
3. HAGER’S REAGENT 
4. WAGNER’S REAGENT 
 
TEST FOR CARBOHYDRATES: 
MOLISCH’S TEST: 
 The aqueous extract of the powdered material was treated with 
alcoholic solution of     - naphthol in the presence of sulphuric acid.   
 
FEHLING’S TEST: 
 The aqueous extract of the powdered material was treated with 
Fehling’s I and II solution and heated on a boiling water bath.   
 
BENEDICT’S TEST: 
 The aqueous extract of the powdered drug was treated with Benedict’s 
reagent and heated over a water bath.   
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TEST FOR GLYCOSIDES: 
GENERAL TEST:  
TEST A: 
200 mg of the powdered drug was extracted with 5ml of dilute sulphuric 
acid by warming on a water bath, filtered and neutralized with 5% sodium 
hydroxide solution.  Then 0.1ml of Fehling’s solution I and II were added, until 
it becomes alkaline and heated on a water bath for 2 minutes. 
 
TEST B: 
200 mg of the powdered drug was extracted with 5ml of water instead 
of sulphuric acid. Boiled and equal amount of water was added instead of 
sodium hydroxide solution.  Then 0.1ml of Fehling’s solution I and II were 
added, until it becomes alkaline and heated on a water bath for 2 minutes. 
 
ANTHRAQUINONES: 
BORNTRAGER’S TEST: 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to 
the filtrate benzene was added and shaken well.  The inorganic layer was 
separated and ammonia solution was added slowly. 
 
MODIFIED BORNTRAGER’S TEST: 
About 0.1gram of the powdered leaf was boiled for two minutes with 
dilute hydrochloric acid and few drops of ferric chloride solution was added, 
filtered while hot and cooled.  The filtrate was then extracted with benzene 
and the benzene layer was separated.  Equal volume of dilute ammonia 
solution was added to the benzene extract and shaken well. 
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TEST FOR CYANOGENETIC GLYCOSIDES: 
Small quantity of the powdered leaf was placed in a stoppered conical 
flask with just sufficient water to cover it.  A sodium picrate paper strip was 
inserted through the stopper so that it was suspended in the flask and it was 
set aside for 2 hours in a warm place. 
 
TEST FOR CARDIAC GLYCOSIDES: 
KELLER KILLIANI’S TEST: 
About 1gram of the powdered leaf was boiled with 10ml of 70% alcohol 
for two minutes, cooled and filtered.  To the filtrate 10ml of water and 5 drops 
of solution of lead sub acetate were added and filtered.  The filtrate was then 
extracted with chloroform and the chloroform layer was separated and 
evaporated to dryness.  The residue was dissolved in 3ml of glacial acetic 
acid containing a trace of ferric chloride. To this 3ml of concentrated sulphuric 
acid was added along the sides of the test tube carefully. 
 
RAYMOND TEST: 
To the alcoholic extract of the leaf, hot methanolic alkali was added. 
 
LEGAL’S TEST:  
To the alcoholic extract of the powdered drug, pyridine and alkaline 
sodium nitro pruside solution were added. 
 
COUMARIN GLYCOSIDES: 
A small amount of powdered leaf was placed in test tube and covered 
with a filter paper moistened with dilute sodium hydroxide solution. The 
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covered test tube was placed on water bath for several minutes.  Then the 
paper was removed and exposed to UV light. 
 
TEST FOR PHYTOSTEROLS: 
The powdered leaf was first extracted with petroleum ether and 
evaporated.  The residue obtained was dissolved in chloroform and tested for 
sterols. 
 
SALKOWSKI TEST: 
Few drops of concentrated sulphuric acid were added to the above 
solution, shaken well and set aside. 
 
LIBERMANN – BURCHARD’S TEST: 
To the chloroform solution few drops of acetic anhydride was added 
and mixed well. 1ml of concentrated sulphuric acid was added through the 
sides of the test tube and set aside for a while. 
 
TEST FOR SAPONINS: 
About 0.5gram of the powdered leaf was boiled gently for 2 minute with 
20 ml of water and filtered while hot and allowed to cool.  5ml of the filtrate 
was then diluted with water and shaken vigorously.   
 
DETERMINATION OF FOAMING INDEX:  
One gram of the coarsely powdered leaf was weighed and transferred 
to 500 ml conical flask containing 100 ml of boiling water.  The flask was 
maintained at moderate boiling, at 80-90oC for about 30 minutes.  Then it was 
cooled and filtered into a volumetric flask and sufficient water was added 
through the filter to make up the volume to 100 ml (V1). 
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Ten Stoppard test tubes were cleaned (height 16 cm, diameter 1.6 cm) 
and marked from 1 to 10.  Measured and transferred the successive portions 
of 1, 2, 3ml up to 10ml and adjusted the volume of the liquid in each tube with 
water to 10ml.  Then the tubes were Stoppard and shaken lengthwise for 15 
seconds, uniformly and allowed to stand for 15 minutes and measured the 
length of the foam in every tube. 
 
TEST FOR TANNINS: 
To the aqueous extract of the powdered leaf, few drops of ferric 
chloride solution were added. 
 
GOLD BEATER’S SKIN TEST: 
2% hydrochloric acid was added to a small piece of gold beater skin 
and rinsed with distilled water and placed in the solution to be tested for five 
minutes.  Then washed with distilled water and transferred to a 1% ferrous 
sulphate solution. 
 
TEST FOR PROTEINS AND FREE AMINOACIDS: 
MILLON’S TEST: 
The acidulous alcoholic extract of the powdered leaf was heated with 
Millon’s reagent. 
 
BIURET TEST: 
To the alcoholic extract of the powdered leaf 1ml of dilute sodium 
hydroxide was added.  Followed by this one drop of very dilute copper 
sulphate solution was added.  
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NINHYDRIN TEST: 
To the extract of the powdered drug, Ninhydrin solution was added, 
and boiled. 
 
TEST FOR MUCILAGE: 
To the aqueous extract of the powdered leaf, Ruthenium red solution 
was added.  
 
TEST FOR FLAVONOIDS 
SHINODA TEST: 
A little amount of the powdered leaf was heated with alcohol and 
filtered.  To the alcoholic solution a few magnesium turnings and few drops of 
concentrated hydrochloric acid were added, and boiled for 5 minutes.   
 
ALKALINE REAGENT TEST: 
To the alcoholic extract of the powdered leaf, few drop of sodium 
hydroxide solution was added. 
 
ZINC HYDROCHLORIDE TEST: 
To the alcoholic extract, mixture of zinc dust and concentrated 
Hydrochloric acid was added. 
 
TEST FOR TERPENOIDS: 
The powdered leaf was shaken with petroleum ether and filtered.  The 
filtrate was evaporated and the residue was dissolved in small amount of 
chloroform.  To the chloroform solution tin and Thionyl chloride were added. 
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TEST FOR VOLATILE OIL: 
About 100gram of fresh leaves, were taken in a volatile oil Clevenger 
apparatus and subjected to hydro distillation for four hours. 
 
TEST FOR FIXED OIL: 
A small amount of the powdered leaf was pressed in between in the 
filter paper and the paper was heated in an oven at 105oC for 10 minutes. 
 
4.3.2. FLUORESCENCE ANALYSIS:  
Powdered leaf material OfP. nigrum was subjected to analysis under 
UV light after treatment with various chemical and organic reagents like 
Ethanol, Ethyl acetate, Chloroform, Water, 50% sulphuric acid, 10% sodium 
hydroxide, 50% nitric acid and dried leaf powder. (Horbone JB, 1973). 
 
4.3.3. ESTIMATION OF FLAVONOID CONTENT:  
[Chang CC et al., 2002, Mabry TJet al., 1970 and Siddiquie MA et al., 
2010]. The flavonoid content of plant extract was estimated by aluminium 
chloride method. In this method, aluminium chloride complexes with 
flavonoids of C3-C5 hydroxyl group and to produce intense colour in acidic 
medium. The intensity of the colour is proportional to the amount of flavonoids 
and can be estimated as quercetin equivalent at wavelength of 415nm. 
 
MATERIALS REQUIRED: 
 Ethanolic extract of leaves of S.aromaticum 
 10%w/v aluminium chloride 
 1M Potassium acetate 
 95%v/v ethanol 
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PROCEDURE: 
0.5ml of the extract (1mg/ml) was transferred to a test tube. To this 
solution, 0.1ml of aluminium chloride, 0.1ml of potassium acetate, 1.5ml 
ethanol were added and made up to 5ml with distilled water. The mixture was 
allowed to stand for 30 min with intermittent shaking. The absorbance was 
measured at 415nm. The calibration curve was generated using quercetin as 
a standard at different concentrations (5-50µg/ml). The reaction mixture 
without aluminium chloride was used as a blank. The flavonoids content was 
expressed as mg of quercetin equivalent per gram of extract. 
 
4.3.4. ESTIMATION OF TOTAL PHENOLIC CONTENT  
(Singleto VL et al., 1979, Gouthamchandra K et al., 2010) 
 
PRINCIPLE: 
The total phenolic content of the extract was determined by Folin&Cio-
calteu’s phenol reagent. This reagent consists of phosphotungstate and 
phosphomolybdate mixture which is reduced to mixture of blue molybdenum 
and tungsten oxides while phenolic content of the extract was oxidized. The 
intensity of colour is proportional to the amount of phenolic content of the 
extract and which was measured at 765nm. The total phenolic content in the 
extract was expressed as milligrams of gallic acid equivalent (GAE) per gm of 
extract.  
 
MATERIALS:  
 Ethanolic extract of leaves ofS.aromaticum 
 10%w/v sodium carbonate solution 
 Gallic acid 
 Folin&Cio-21021calcateu’s phenol reagent 
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PROCEDURE: 
0.5ml and 1ml of extract was transferred into separate test tube. To this 
solution, FCR 0.5ml and 1ml of sodium carbonate were added and final 
volume made up to 10ml with distilled water. The mixture was allowed to 
stand for 1hr with intermittent shaking. The absorbance was measured at 
765nm. A calibration curve was generated using Gallic acid as a standard at 
different concentrations (2, 4, 6, 8, 10µg/ml). The reaction mixture without 
sample was used as a blank. The total phenolic content was expressed as 
milligrams of Gallic acid equivalent (GAE) per g of extract. 
 
4.3.5 DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF 
Syzygium aromaticum BY ENERGY DISPERSIVE X-RAY 
SPECTROMETER (EDS): 
The SEM allows the observation of materials in macro and submicron 
ranges. SEM is capable of generating 3-D images for analysis of topographic 
features. When SEM is used along with EDS the analyst can perform an 
elemental analysis on specimens of microscopic sections or contaminants 
that may be present. 
 
EDS ANALYTICAL CAPABILITIES: 
Backscattered electron images in the SEM display compositional 
contrast that results from different atomic number elements and their 
distribution. EDS is used to find particular elements are and their Atomic %.  
The Y-axis shows the counts (number of X-rays received and processed by 
the detector) and the X-axis shows the energy level of those counts [Bob 
Hofner]. 
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By Viewing 3-D images of specimens solves some of the problem in an 
analysis and it is also necessary to detect different elements associated with 
the specimen. This is accomplished by using the “built-in” spectrometer called 
an Energy Dispersive X-ray Spectrometer. 
 
EDS SYSTEM COMPRISES OF 3 BASIC COMPONENTS: 
 An X-ray Detector - detects and converts X-ray into electronic signals. 
 A Pulse Processor - measures the electronic signals to find out energy 
of each X-ray detected; and 
 A Multiple Channel Analyser - interprets and displays analytical data.                      
 
EDS is an analytical technique in which the specimen emits X-rays due 
to the bombardment of electron beam on it which is used to identify the 
elemental composition of the specimen due to the ejection of electrons from 
the atoms on the specimen surface. To explain further, when the sample is 
bombarded by the electron beam of the SEM, electrons are ejected from the 
atoms on the specimen’s surface. A resulting electron vacancy is filled by an 
electron from a higher shell, and an X-ray is emitted to balance the energy 
difference between the two electrons. The EDS X-ray detector measures the 
number of emitted X-rays emitted versus their energy.The energy of the X-ray 
is characteristic of the element from which the X-ray was emitted. A spectrum 
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of the energy versus relative counts of the detected x-rays is obtained and 
evaluated for the determinations of the elements. 
 
4.3.6 IDENTIFICATION OF COMPOUNDS PRESENT IN THE VOLATILE 
OIL OF LEAVES BY GC-MS ANALYSIS. 
GAS CHROMATOGRAPHY 
GC now ranks as the most important technique in analytical chemistry 
because of its several advances in its instrumentation. GC requires the 
vapourization of sample at the injection point which is carried by carrier gas 
(mobile phase) at a suitable temperature and pressure. The carrier gas which 
passes through the injection point is heated to the temperature of stationary 
phase (column) or heated injection block or if flash heater is used to about 
50ºC above that of the column. The sample must be stable when vaporized 
and also its passage through the packed column, in order to avoid the 
production of complex chromatogram (carrier gas elutes the product from the 
column) and also when vaporized. The instantaneous vapourisation of sample 
and the detector produces an electrical output proportional to the amount of 
compound emerging from the column. 
 
MASS SPECTROMETRY 
Wien, in 1898, produced the first crude mass spectra when he 
demonstrated that positive ions could be deflected according to their masses 
in electric or magnetic fields. This observation was developed by Thompson 
(1910) who used combined electrostatic and a magnetic field to observe the 
mass spectrum of mixture of rare gases. 
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In single focusing mass spectrometer the sample is introduce into the 
instrument in such a way that its vapour is bombarded by electrons having an 
energy of about 70eV. Positive ions formed in ion source are accelerated 
between two plates by potential difference of a few thousand volts (V). The 
ions pass through the source slit and are deflected by magnetic field (H) 
according to their mass/charge ratios. They then pass through the exit or 
collector slit and impinge upon the collector; the signal received is amplified 
and recorded. The height or intensity of the resulting peak is proportional to 
the ion abundance. 
 
COMBINATION OF GC WITH MASS SPECTROMETRY 
The identification of fractions in gas chromatography is essentially 
comparative, in that the characteristic of the unknown are compared with 
those of known library compound. By correct choice of column, the fraction 
consists of single substance only, so that, if each is examined by other 
methods for identification, a powerful analytical tools becomes available. This 
may be done in several ways and GC is now used in conjuction with IR 
spectra and mass spectra. 
 Gas liquid chromatography is a very effective method for separating a 
complex mixture into its individual components. The high sensitivity of mass 
spectrometry provides the necessary information for either identification of 
compounds by comparison with available spectra or structural elucidation of 
small quantities of compounds. Gases and volatile liquids are admitted to the 
source through a small leak from the gas reservoir.Hence GC-MS is the 
introduction of GC effluents without most of carrier gas into a mass 
spectrometer has its increasing utility in structural organic chemistry, 
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pharmaceutical analysis and biochemistry. Here the fractions which 
elutesfrom GC column is condensed into a capillary or onto a small metal 
surface and this fractions are introduced into the MS source. For 
multicomponent mixture many operations are involved and losses may occur 
during the collection of fractions; however, the mass spectrometer may be 
operated at high resolution and GC carrier gas is admitted to the instrument. 
GC/MS combination produce a wealth of data rapidly. To process and 
interpret all of this data manually would be excessively time consuming. 
 
Instrument Name   :   JEOL GC MATE  11 
Front inet temp   :    220oC 
Column     :    HP 5 Ms 
Carrier gas    :   High Pure Helium Gas  
Flow Rate    :  1 ml/ min 
Oven Tem    : 50 to 250 @ 10 deg /min 
Ion chamber temp         :   250 o C 
GC interface Tem           : 250o C 
Mass analyser                : Quadrupole with double focusing  
      massanalyser 
Detector                         :     Photon Multiplier Tube  
Scan                                :  50 to 600 amu 70 ev 
 
4.3.7 Preparation of nanospheres of volatile oil of the leaves of    
S.aromaticum (SALVONS): 
 VO of the S.aromaticum leaves is encapsulated in to a 1:1(w/w) 
polymer blend of MC and EC at a VO to EC/MC polymer weight ratio of 1:1 by 
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displacing the ethanol solvent with water, as reported ( Sansukcharearnpon et 
al., 2010). To this end, the two polymers (125mg EC and 125 mg MC) were 
dissolved in 25 ml of 75% (v/v) aqueous ethanol at 70o C, allowed to cool to 
room temperature and then (250mg) added and dispersed. After mixing water 
was slowly dropped (0.75ml/min) in to the mixture to a final volume of 100ml. 
To determine the encapsulation efficience (EE) and loading capacity the 
suspension was filetered , centrifuged through a 100,000 Da MW cut off 
membrane at 9392X g for 10 min and the obtained clear supernatant was 
quantified for eugenol contentby UV spectrophotometry, measuring the 
absorbance at a wavelength of 275nm with refernece to a freshly prepared 
calibration curve. The EE and VO loading level were then determined as 
follows: 
 % EE=Wt of VO in spheres /Wt of VO used X 100 
 % Loading level =Wt of VO in spheres /Wt of VO in spheres+ Wt of 
polymerX 100 
 
4.3.8 Characterisation of nanospheres: 
 The aqueous suspension of VO loaded particles was subjected to 
analysis by SEM. 
 
4.4  PHARMACOLOGICAL STUDIES: 
4.4.1 ACUTE TOXICOLOGICAL STUDY USING BRINE SHRIMP 
LETHALITY ASSAY (BSLA): 
 (Michael AS et al., 1956, Vanhaecke P et al., 1981, Sleet RB and 
Brendel K., 1983)  
 
FIGURE 8 
LIFE CYCLE OF ARTEMIA NAUPLII 
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 The importance of medicinal plants and traditional health systems 
solving the health care problems of the world is gaining increasing attention. 
Most of the developing countries have adopted traditional medical practice as 
an integral part of their culture. 
 In order to study the toxicity of these medicinal plants we performed 
Brine Shrimp Lethality Bioassay which based on the ability to kill laboratory 
cultured brine shrimp (Artemia nauplii). The brine shrimp assay is a useful tool 
for preliminary assessment of toxicity and it has been used for the detection of 
fungal toxins, plant extract toxicity, heavy metals, pesticides and cytotoxicity 
testing of dental materials. 
 The method is attractive because it is very simple, inexpensive and low 
toxin amount are sufficient to perform the test in the micro well scale. 
 
PRODUCTION OF Artemia nauplii: 
 Artemia a non-selective filter feeder of organic detritus, micro algae 
and bacteria. Artemia are naturally found in saltpans, hyper saline lakes and 
coastal lagoons as well as in the manmade saltpans. When the cysts are 
inoculated in seawater for 24hrs the free-swimming nauplii are hatched out. 
 
CYTOTOXICITY BIOASSAY:  
 Ten nauplli were drawn through a glass capillary and placed in each 
vial containing 4.5ml of brine solution. In each experiment, 0.5ml of the extract 
was added to 4.5 ml of brine solution and maintained at room temperature for 
24hrs under the light and surviving larvae were counted. Experiment was 
conducted along with control (vehicle treated), different concentrations of the 
aqueous extract (100-7500 ppm) in a set of three tubes per dose. 
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LETHALITY CONCENTRATION DETERMINATION: 
 The percentage lethality was determined by comparing the mean 
surviving larval of the test and control tubes. LC50 value was obtained from the 
best – fit line, plotted concentration verses percentage lethality. 
Podophyllotoxin was used as a positive control in the bio assay. 
 
ABBOT’S FORMULA: 
  
 
4.4.2. EFFECT OF VOSAL ON MUTAGENESIS OF Drosophila 
melanogaster (Frei.H&Wurgler.E.F 1998). 
 Due to its lack of information about its mutagenic effect,So it is 
important to evaluate the effect on mutagenic alterations. Over the last few 
years, mutagenic assays have been developed that are able to detect several 
genetic endpoints. In genetic toxicology, it is important to know whether 
chemical should regarded as hazardous or whether they can be considered 
as sufficiently below a defined minimal effect level. 
 The eye and wing spot assays have received increasing interest in the 
recent past. Because they are sensitive in vivo assays which are simple to 
carry out. They are also much less laborious, cheaper, and at the same time 
more informative. 
 In addition it is well established that Drosophila possess versatile 
system and has proved to be an assay for mutagenic screening which is easy 
to perform and inexpensive for the detection of promutagens. 
𝐂𝐎𝐑𝐑𝐄𝐂𝐓𝐄𝐃 𝐌𝐎𝐑𝐓𝐀𝐋𝐈𝐓𝐘(%) 
𝐓𝐄𝐒𝐓 𝐌𝐎𝐑𝐓𝐀𝐋𝐈𝐓𝐘(%) − 𝐂𝐎𝐍𝐓𝐑𝐎𝐋𝐌𝐎𝐑𝐓𝐀𝐋𝐈𝐓𝐘(%)
𝟏𝟎𝟎 − 𝐂𝐎𝐍𝐓𝐑𝐎𝐋 𝐌𝐎𝐑𝐓𝐀𝐋𝐈𝐓𝐘(%)
 100 
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 If a mutagenic alteration takes place in one of the cells, the descendent 
cells will form a clone of mutant cells that can be detected as a spot in the 
adult tissue. 
 The test can detect the mutagenic chemical compound that produced a 
loss of heterozygosis by several chromosome breakage mechanisms such as 
mitotic recombination, deletion, point mutation, chromosomal loss and 
aberration of Drosophila melanogaster: (AsbhurnerM, Wright TRF 2005, Golic 
KG, Hawley RS 2005) 
 Drosophila is a genus of small flies, belonging to the family 
Drosophilidae, whose members are often called “fruit flies” or more 
appropriately (though less frequently) pomace flies, vinegar flies, or wine flies, 
a reference to the characteristic of many species to linger around overripe or 
rotting fruit. These feed primarily on unripe or ripe fruit, with many species 
being regarded as destructive agricultural pests, especially the Mediterranean 
fruit fly. One species of Drosohila in particular, D.melanogaster, has been 
heavily used in research in genetics and is a common model organism in 
developmental biology. Indeed, the terms “fruit fly” and “Drosophila” are often 
used synonymously with D.melanogasterin modern biological literature. 
 
PHYSICAL APPEARANCE OF D.melanogaster: 
 Fruit flies have brick red eyes, are yellow-brown in colour, and have 
transverse black rings across their abdomen. They exhibit sexual dimorphism; 
Females are about2.5millimeters (0.1 inches) long; males are slightly smaller 
and the back of their bodies is darker. Males are easily distinguished from 
females based on colour differences, with a distinct black patch at the 
abdomen, less noticeable in recently emerged flies, and the sex combs (a row 
LIFE CYCLE OF Drosophila melanogaster 
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of dark bristles on the tarsus of the first leg). Furthermore, males have a 
clusterof spiky hairs (claspers) surrounding the reproducing parts used to 
attach to the female during mating. 
 
LIFE CYCLE AND REPRODUCTION OF D.melanogaster: 
 The developmental period for D. melanogaster varies with temperature, 
as with many ectothermic species. The shortest development time (egg to 
adult), 7 days is achieved at 28oC. Development time increase at higher 
temperatures 30oc, 11 days due to heat stress. Under ideal conditions, the 
development time at 25oC (77oF) is 8.5 days. Under crowed conditions, 
development time increases, while the emerging flies are smaller. Female lay 
some 400 eggs (embryos), about five at a time, in to rotting fruit. The eggs, 
which are about 0.5 millimetre long, hatch after 12-15 h (at 25oC (77oF)). The 
resulting larvae grow for about 4 days (at 25oC) while molting twice (into 2nd- 
and 3rd-instar larvae), at about 24 and 48 h after hatching. During this time, 
they feed on the microorganisms that decompose the fruit, as well as on the 
sugar of the fruit itself. Then the larvae encapsulate in the puparium and 
undergo a four-day-long metamorphosis (at 25oC), after which the adults 
eclose (emerge). 
 
MODEL ORGANISM: (Adams MDetal.,2001) 
 Drosophila melanogaster is one of the most studies organisms in 
biological research, particularly in genetics and developmental biology.  
 
THERE ARE SEVERAL REASONS: 
 The care and culture requires little equipment and use little space even 
when using large cultures, and the overall cost is low. 
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 It is small and easy to grow in the laboratory and their 
morphology is easy to identify once they are anesthetized 
(usually with ether, carbon dioxide). 
 It has a short generation time (about 10 days at room 
temperature) so several generations can be studied within a few 
weeks. 
 It has high fecundity (females can lay more than 800 eggs in a 
life time, i.e. one egg every 30 minutes with sufficient food). 
 Males and females are readily distinguished and virgin flies are 
easily isolated, facilitating genetic crossing. 
 It has only four pairs of chromosomes: three autosomes, and 
one sex chromosome. 
 Genetic transformation techniques have been available since 
1987. 
 Its complete genome was sequenced and first published in 
2000. 
 
SIMILARITY TO HUMANS:(Bloomington Drosophila Stock center at Indiana 
University) 
 About 75% of known human disease genes have a recognizable match 
in the genetic code of fruit flies and 50% of fly protein sequences have 
mammalian analogues. An online database called homophilia is available to 
search for human disease gene homologues in flies and vice versa. 
Drosophila is being used as genetic model for several human diseases 
including the neurodegenerative disorders Parkinson’s, Huntington’s, 
spinocerebellar ataxia and Alzheimer’s disease. The fly is also being used to 
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study mechanisms underlying aging and oxidative stress, immunity, diabetes 
and cancer as well as drug abuse. 
 
MATERIALS AND METHODS: 
 Stereomicroscope 
 Micropipettes 
 Diethyl ether 
 Stage micrometer 
 Eyepiece micrometer 
 Formaldehyde (0.5%V/V) 
 VOSAL  the concentration of 1, 2 and 4µl/ml conc 
 Plastic containers  
 70%V/V Ethanol  
 Standard fly food   
 Petridishes. 
 
EXPERIMENTATION: 
1. IInd in star larvae from F1 generation of normal flies were collected. 
2. Larvae were washed with solution of 20% W/V sucrose and seeded in 
glass petridishes (20 larve/vial) containig 2 gm of fly food with 1ml of 
total alkaloid extract of various concentration (10, 20 µg/ml) along with 
negative control of solvent alone (distilled water) and standard 
chemical mutagen(0.5% V/V formalin). 
3. Larvae were fed on the above medium for six hours and transferred to 
fresh medium for the rest of their development. 
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4. After eclosion, adult flies were collected and stored in70%V/V ethanol 
for the evaluation for the evaluation of the mutagenic effect. 
5. Morphological changes including eye colour, spots in the wings, wing 
hairs, changes in the length and width of the wing, wing shape, 
abdomen length and total body length were observed under 
stereomicroscope. 
6. All the experiments were carried out at room temperature (±12h day 
and night). 
 
REPRESENTATIVE Drosophila MODELS OF ALZHEIMER’S DISEASE: 
 Drosophila has emerged as an excellent model system for   
neurodegenerative diseases including Alzheimer’sdisease (AD) and 
Parkinson’s disease (PD) because of genetic homology, ease of genetic 
manipulation, and well-conserved disease-associated genes. Drosophila 
geneticists have successfully used these models to identify many diseases 
associated genes, which sheds light on our understanding of the pathology of 
these diseases. 
 Alzheimer disease (AD) is the most common neurodegenerative 
disease, which causes a deficiency in memory and   cognitive functions. The 
chief event in AD pathogenesis is the accumulation of amyloid 𝛽-peptide 42 
(A𝛽42), a form of 𝛽-amyloid precursor protein (APP) proteolytically processed 
by𝛾-secretase. Aggregates of abnormally phosphorylated, a microtubule-
binding protein, tau are also shown to be closely associated with neuronal 
loss in AD. The Drosophila genome contains genes that encode orthologs of 
APP, tau, and four major protein components of 𝛾-secretase (presenilin, 
nicastrin, APH-1, and PEN-2). Transgenic flies expressing human A𝛽42 or tau 
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ectopically developed late onset neuronal degeneration and had a shortened 
lifespan. Drosophila AD models present various easilyvisible and quantifiable 
phenotypes such as eye degeneration, locomotor defects, shortened lifespan, 
developmental defects, learningand memory defects increased oxidative 
stress sensitivity, which make it suitable for in vivo genetic screening.  
 The experimental methods foranalysing these phenotypes are 
described as: Based on genetic screening using Drosophila models of AD, 
several biochemical processes such as secretion, regulation of chromatin 
structure, and cholesterol homeostasis have been found to be involved in 
mediating the toxic effects of A𝛽42. 
 In tau-expressing models, kinases and phosphatases comprised the 
major classes of modifiers ofthetauopathy, and cytoskeleton proteins and 
molecular chaperones have been identified as modulators of mutant tau-
induced neurodegeneration. More recently, DNA damage-activated 
checkpoint kinase 2, histone deacetylase6, and epidermal growth factor 
receptor (EGFR) have been reported to be implicated in AD pathologies in 
Drosophila AD models. Moreover, several in vivo reporter systems for 
measuringAPP𝛾-secretase activity were developed in Drosophila. Among 
them, the transgenic system consisting of the human APP and the yeast 
GAL4 fusion protein under the expression of the eye-specific glass multimer 
reporter (GMR) promoter has been applied as a powerful genetic screening 
tool for isolating 𝛾-secretase activity-regulating molecules. In this, the 
presence of 𝛾-secretase activity, the intracellular domains of APP and GAL4 
translocate to the nucleus and induce GRIM expression, which results in cell 
death in the eye. Therefore, genetic or pharmacological modulators of 𝛾-
CHAPTER IV                                                     MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY,COP, MMC, MADURAI      Page 94  
secretase activity can be screened by simply observing the eye degeneration 
phenotype. Several genetic modulators of 𝛾-secretase activity were also 
identified using this reporter system. 
 
REPRESENTATIVE NEUROLOGICAL PHENOTYPES OF Drosophila 
MODELS OF AD AND PD: 
 Neurodegenerative disease models of drosophila show a variety of 
phenotypes, which are very similar to the symptoms of human patients and 
closely linked with the neuropathology of the diseases. These phenotypes 
include a wide range of biological processes, from cellular phenotypes to 
behaviours. These prominent and easily observable phenotypes make 
Drosophila a valuablemodel for drug screening and discovery of novel 
disease associatedgenes. 
 Accumulation of A𝛽42 and𝛼-syn. One of the major characteristics of 
AD is the accumulation of amyloid protein in the cerebral cortex. Mutation in 
APP, Presenilin 1, and Presenilin 2 genes or other factors increases A𝛽42 
production and accumulation. Consequently, increased A𝛽42 oligomerization 
and deposition injure the neurons, causing neuronal dysfunction and cell 
death.                                                                                        
 These AD-like phenotypes can also be observed in Drosophila AD 
models. Over expression of A𝛽42 in the nervous system induces neuronal 
loss accompanied by the accumulation of A𝛽42 in the adult brain. Similarly, 
PD as a neurodegenerative disease is characterized by the loss of 
nigrostriatal DA neurons and the accumulation of Lewy bodies in neurons. 
Over expression of 𝛼-syngene in the nervous system of the fly model results 
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in the death of DA neurons and the formation of Lewy body-like filamentous 
intraneuronal inclusions. 
 Eye Degeneration. Although the central nervous system is the main 
target of neurodegenerative diseases such as AD, PD, and Huntington’s 
disease (HD), functional defects in these diseases are not restricted to the 
brain. For example, extensive ganglion cell loss was observed in the central 
retina of AD patients, and visual dysfunction caused by retinal degeneration 
has been found in multiple transgenic AD mouse lines. Thus, tissues other 
than that of the brain can be used to identify the function of genes related to 
neurodegenerative diseases. Eyes are prominent organs in the body of 
Drosophila. Therefore, an ocular phenotype is easily distinguishable and 
facilitates simple, easy, and efficient genetic or pharmacological screening. 
Moreover, the developing Drosophila eye contains the photoreceptor neurons. 
Drosophila has two compound eyes, each consisting of about 800 ommatidia 
and bristles. These ommatidia are arranged very regularly. Using the UAS-
GAL4 system, the expression of a human disease-related transgene in the fly 
eye creates a fly model for neurodegenerative disease as well as helps to 
discover the function of the gene. For example, overexpression of the A𝛽42 
and tau genes involved in AD or the 𝛼-syngene involved in PD induces 
apoptotic eye degeneration, reduced eye size, and deformed ommatidia. 
 
Drosophila strains:  
 The strains used in the study Aβ42 expressing Drosophila 
melanogaster. 
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4.4.3 In vivo EFFECT ON THE TRANSGENIG Drosophila melanogaster 
MUTANT WITH  Aβ42  INDUCED NEURODEGENERATION OF VOSAL 
4.4.3.1 EFFECT OF VOSAL ON LONGEVITY OF  Aβ42 EXPRESSING 
Drosophila (Fai C Ng et al., 2013) 
  n= 30 
Normal control- Not expressing Aβ maintained at the normal diet Aβ 
expressing control – Maintained on the normal diet 
 Positive control – Diet containing 10 µmol donepezil/gm of Drosophila 
food medium 
 Treated groups- Diet containing 1, 2 and 4mg leave oil /gm of 
Drosophila food medium 
 Dead drosophila are counted on day 1 and 5 in a seven days cycle. 
The feeding lasted for 65 days  
 
4.4.3.2 EFFECT OF VOSAL ON LOCOMOTOR FUNCTION BY CLIMBING 
ASSAY OF Aβ42 EXPRESSING Drosophila(Fai Ng C et al., 2013).  
 Locomotor function of drosophila was measured according to the 
climbing assay. 30 drosophila are placed at the bottom of 15ml stout wall test 
tube and were given 10sec to climb up the tube. At the end of the trail the 
number of drosophila that climbed up to a vertical distance of 8cm or above 
was recorded. They were tested on day1 and 5 in a seven day cycle in 
triplicate. 
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4.4.3.3 PSEUDOPUPIL TECHNIQUE TO VISUALIZE THE RETINO 
RHABDOMERES IN ADULT EYES: 
 The control, positive and Aβ42 were treated as above. Drosophila 
heads were examine under light microscope. The compound eye of 5days old 
drosophila was viewed under microscope. Each photoreceptor projected, the 
rhapdomere, in to the center of the ommatidium which are appeared as bright 
spots and rhabdomeres in each ommatidium were counted (in the control 
seven rhabdomere could be observed in an each ommatidium) 100 ommatidia 
were observed from 5-10 eyes and the average rhabdomeres count per 
ommatidium was calculated. Three trails were contacted for each group 
 
4.4.3.4. EVALUVATION OF SURFACE ORGANIZATION OF OMMATIDIA IN 
ADULT EYES BY NAIL – POLISH IMPRINTS AND SEM: (Arya R and 
Lakhotia S C 2006) 
 Recently, fly models for different human neurological and other genetic 
disorders was also been developed and  widely used for identifying interacting 
genes and for developing therapeutic strategies . The compound eyes of flies 
have been particularly useful in this situation because 
 The genetic pathways that determine eye development are understood 
better,  
 The adult eyes contain both neuronal and non-neuronal cell types, 
 They are dispensable for survival of the flies, and 
 The phenotypic consequences of any perturbations in eye 
development are distinct and quantifiable.  
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 The adult Drosophila eye contains about 800 highly ordered matrix 
ommatidia arrangement with arrays of sensory bristles projecting out from the 
surface of each ommatidial unit. 
 To exploit these features of the Drosophila eyes researchers use 
scanning electron microscopy (SEM) to examine any disruption in the ordered 
arrays of the ommatidia in adult eyes.  A novel, simple and inexpensive 
method that provides high quality images, comparable to those obtained by 
SEM, of the external surface of eyes of adult flies, but which does not require 
expensive facility and can be used in any laboratory with a good light 
microscope was described 
 In this method, a transparent nail polish is used to create an exact 
replica of the external surface of the eye, which is subsequently examined 
using a light microscope. An imprint of adult eye is obtained by a small drop of 
transparent nail polish placed on the surface of a clean glass slide. The fly to 
be examined is anaesthetized, placed on a dry area of the slide and 
decapitated with a sharp blade or needle. The decapitated head is held with 
forceps or needles and is briefly dipped in the still fluid drop of nail polish. The 
head is then placed in a clean and dry area of the same slide and the nail 
polish layer on the eyes is allowed to dry at room temperature (preferably 
24°C) for 5– 10 min. The dried layer of nail polish can be easily peeled-off 
from the eye with the help of fine dissecting needles. The separated peel, 
being an exact replica of the eye surface, assumes a goblet-shaped 
appearance. This peel is carefully placed on another clean glass slide with the 
imprint side facing upright. This nail polish imprint can be directly examined 
and photographed under a stereo binocular microscope to provide a low 
CHAPTER IV                                                     MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY,COP, MMC, MADURAI      Page 99  
magnification image of the eye surface. For higher magnification and for 
better image of the eye surface, the peel is carefully flattened by gently 
placing a cover slip over it and carefully applying a slight pressure. The eye 
imprint is then examined under a microscope using 10X, or 45X differential 
interference contrast (DIC) objective. These can be seen with bright field 
optics as well, but the DIC optics provide a better image. Details of eye 
surface are generally comparable with those obtained by SEM. The nail polish 
imprints also easily reveal the characteristic defects due to different mutants 
affecting eye development.  
 We performed both nail polish imprint technique and SEM to analyse 
the external surface of the eye of Drosophila. 
 
 
 
  
 
RESULTS 
 
 
 
FIG – 1 
DIAGRAM SHOWING THE AERIAL PARTS OF  S.aromaticum 
 
 
 
 
 
 
 
PLATE 1 
 HABIT AND HABITAT OF S. aromaticum 
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RESULTS 
 
5.1 PHARMACOGNOSY:  
5.1.1 MORPHOLOGICAL FEATURES OF Syzygium aromaticum (PLATE 
1, FIG 1) 
Clove tree is a small ,handsome evergreen tree.,reaching 12-15m in 
height. 
 
LEAVES : (PLATE 2,3) 
Shape         : Leaves are simple, opposite, coriaceous,  
   exstipulate, glabrous and aromatic 
Size            : 7.5-12.3 x2.5-3.75 cm     
Color   : Green  
Margin        : Entire  
Base            : Cuneate 
Apex            : Shortly or broadly blunty acuminate  
 Petiole       : 2-3 cm long 
 
STEM         
 The trunk up to 30 cm in diameter is composed of very hard wood.If 
often forks near the base into two or three main erect branches. 
 
FLOWERS: (PLATE 4) 
 The inflorescence is a terminal, corymbose,trichotomous panicle, 
shortly pedunculate and branched from the base. The flower is hermaphrodite 
with a fleshy hypanthium which is surmounted by the sepals.The four calyx 
Plate 2 
BRANCH  OF  S.aromaticum  SHOWING  LEAF  ARRANGEMENT 
 
 
 
PLATE 3 
DORSAL AND VENTRAL VIEW  OF  S. aromaticum  LEAF 
                                
                                                       
 
PLATE 4 
FLOWER AND FLOWER BUD OF  S. aromaticum 
 
PLATE 5 
FRUIT OF S. aromaticum 
 
PLATE  6 
SEED OF S.aromaticum 
 
PLATE 7 
ROOT  OF  S.aromaticum 
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lobes are fleshy,triangular,slightly incured.The four petals are imbricate,tinged 
red,rounded. 
 
Colour :     Greenish,turning pink at the time of maturity 
Stamens :  Stamens are very numerous,appearinggrouped in 
   four masses. 
Anther             :      Pale yellow,ovate,opening longitudinally wit small 
   pale brown in colour 
 
FRUITS(PLATE 5) 
Shape        :   Oblong,fleshy, drupes 
Size           :  The friuts are  2-3mm thick 
Colour         :  Reddish purple in colour 
 
SEEDS  (PLATE 6) 
Shape       :    Oblong,soft,grooved on one side,  
Size          :    1.5 cm long       
 
 
ROOT (PLATE 7) 
 The seedlings produces a pronounced tap root  which remains 
relatively Short and is fairly quickly replaced by two or three primary sinkers 
which develop from it. 
 
5.1.2 MICROSCOPY OF THE LEAF  
LEAF MIDRIB (PLATE 8,9) 
  T.S of  Midrib  grooved from above erect downward flat  on the adaxial 
side, And convexity  on the adaxial side. 
 
PLATE  8 
T.S OF LEAF THROUGH MIDRIB [MICROTOME SECTION] 
 
T.S   OF  MIDRIB [HAND SECTION] 
 
 
PLATE 9 
MIDRIB ENLARGED [MICROTOME SECTION] 
 
 
A PORTION OFLAMINA ENLARGED  [MICROTOME SECTION] 
 
 
 
  
 
FIGURE 2 
T S OF LEAF OF S.aromaticum THROUGH MIDRIB 
[HAND DIAGRAM] 
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EPIDERMIS :(PLATE 10) 
 It is made up small rectangular thick wall uniseriatecells, covered by a 
thick cuticle. In surface view polygonal in shape.  
 
STOMATA:  
 Amphistomatic,ranunculaceous few in upper and more in lower 
epidermis. 
 
LAMINA (PLATE 10, 11): 
              Transverse section of lamina shows an upper epidermis with a 
cuticle. Stomata are present on both the epidermis followed by two layer of 
palisade cells containing chloroplasts.  The spongy mesophyll is made up of 2 
- 4 layers of cells and seen in between the palisade and lower epidermis cells. 
Some of the cells of the spongy parenchyma contain oil contents as secretary 
cavities developed initially schizogenous but ultimately lysigenous at maturity 
with a breakdown of all the secretary cells within the gland lumen. Oil cavities 
located close to both surfaces, glandular and lined with epithelial like cells. 
Cells containing tannin are very common. 
 
VASCULAR BUNDLES (PLATE 8,9    FIG 2 ) 
  The vascular system consists of a U shaped or almost closed 
circle of separate collateral vascular bundles.  Small vascular bundles are 
scattered towards the peripheral region.  Each vascular bundle is encircled by 
a single row of bundle sheath.   
 
 
 
PLATE  10 
STOMATA (RANUNCULACEOUS) 
       UPPER  EPIDERMIS     LOWER  EPIDERMIS 
 
                           
 
                        VENATION PATTERN  OF  S.aromaticum  
 
  
 
 
 
PLATE 11 
SCHIZOLYSIGENOUS  OIL GLAND ENLARGED 
[MICROTOME SECTION] 
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GROUND TISSUE:  
 The ground tissue is made up of parenchymatous thin walled oval to 
circular, closely arranged cells with small intercellular spaces.   
 
VENATION PATTERN (PLATE 13): 
 Distinct vein islets are formed by the secondary and tertiary veins. Vein 
islets are small and clearly seen, some of the vein terminations are forked. 
 
T.S OF PETIOLE: (PLATE 12,13  FIG 30) 
SHAPE:  
Transverse section of petiole is oval in shape with a depression on the 
centre of the adaxial surface. 
 
EPIDERMIS:  
 It has epidermal singlelayer of thick walled small rectangular cells with 
smooth thick cuticle 
 
VASCULAR BUNDLE:  
The Vascular system consists of single U shaped open circle vascular 
bundles.  Ground tissue: It consists of parenchymatous cells. Large secreting 
cavities are present. 
 
5.1.3 MICROSCOPICAL STUDY OF LEAF USING SCANNING ELECTRON 
MICROSCOPE:(PLATE 18) 
SEM is a powerful magnification tool that utilizes focused beams of 
electrons to obtain information.  The high resolution, three dimensional 
images produced by SEMS provide topographical, morphological & 
compositional information.  
PLATE 12 
T.S OF PETIOLE 
(MICROTOME  SECTION ) 
 
T.S  OF PETIOLE [HAND SECTION] 
 
 
 
 
 
PLATE 13 
T.S OF PETIOLE ENLARGED 
 
 
 
 
 
 
 
                                                           
PLATE 14 
SEM  OF  S. aromaticum 
  
                    
 
 
 
 
 
 
 
FIGURE 3 
T S OF PETIOLE [HAND DIAGRAM] 
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 SEM study of leaf provides detailed surface information. Adaxial and 
abaxial epidermal surface is smooth with no ornamentation.  Trichomes are 
absent.  Stomata are confined to the abaxial surface only.  
 
5.1.4  POWDER MICROSCOPY  
ORGANOLEPTIC CHARACTERS 
 Nature :  Coarse 
 Colour :  Dark green. 
 Odour :  Characteristic 
 Taste :   Aromatic 
 Pressed in between two filter paper : No oil mark on the paper. 
We have observed the following microscopical cell structures, 
 Secretory cavity 
 Ranunculaceous stomata 
 Xylem 
 Phloem with companion cells 
 Fibres 
 Parnenchyma cells 
 Schyzolysigenous cells 
 
5.1.5  MICROSCOPIC SCHEDULES 
As per the methods described in materials and methhods, microscopic 
schedules were carried out and the results tabulated from the Tables 1- 4 
 
 
 
 
 
FIGURE - 4 
POWDER MICROSCOPICAL CHARACTER OF S.aromaticum 
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Table – 1 
VEIN ISLET AND VEIN TERMINATION NUMBER 
OFSyzygium aromaticum   LEAVES 
 
 
 
 
 
 
 
 
 
OBSERVATION 
NUMBER 
VEIN ISLET NUMBER 
VEIN TERMINATION              
NUMBER 
1 8 6 
2 7 6 
3 8 6 
4 7 6 
5 6 5 
6 7 6 
7 6 4 
8 8 7 
9 8 5 
10 7 6 
Minimum 6 4 
Average 7.2 5.7 
Maximum 8 7 
CHAPTER V                                                                                 RESULTS 
  
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI       Page 106 
 
 
Table 2 
STOMATAL NUMBER OF S.aromaticum  LEAVES 
 
OBSERVATION      
NUMBER 
UPPER 
EPIDERMIS 
LOWER 
EPIDERMIS 
1 5 9 
2 4 8 
3 3 6 
4 4 8 
5 3 8 
6 4 8 
7 5 9 
8 5 8 
9 3 8 
10 5 7 
Minimum 3 6 
Average 4.1 7.9 
Maximum 5 9 
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Table – 3 
STOMATAL INDEX OF S.aromaticum LEAF 
 
OBSERVATION      
NUMBER 
UPPER EPIDERMIS LOWER EPIDERMIS 
1 24 42 
2 26 40 
3 28 35 
4 26 37 
5 23 39 
6 26 48 
7 24 44 
8 24 45 
9 26 44 
10 28 46 
Minimum 23 35 
Average 25.5 42 
Maximum 28 48 
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Table – 4 
PALISADE RATIO OF S.aromaticum LEAF 
 
S.NO PALISADE RATIO 
1 4 
2 3 
3 3 
4 5 
5 4 
6 3 
7 4 
8 3 
9 4 
10 4 
Minimum 3 
Average 3.7 
Maximum 5 
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5.1.6 PHYSICO CHEMICAL PARAMETERS 
As per the methods described in materials and methods, 
physicochemical parameters were carried and the results were as follows. 
 
Table – 5 
ASH VALUES OF THE  S.aromatium LEAVES 
 
 
OBSERVATION 
NUMBER 
TOTAL ASH 
(%) 
ACID 
INSOLUBLE 
ASH (%) 
WATER 
SOLUBLE 
ASH (%) 
 1 7.5 0.7 - 
2 7.9 0.6 - 
3 7.5 0.9 - 
4 7.06 0.6 - 
5 7.14 1.1 - 
6 7.5 - 1 
7 7.18 - 1.12 
8 7.03 - 1.05 
9 7.05 - 1.02 
10 7  - 1.06 
 
ASH MINIMUM AVERAGE MAXIMUM 
TOTAL 
ASH 
 
7.03 
7.286 7.9 
ACID INSOLUBLE ASH 0.6 0.78 1.1 
WATER SOLUBLE ASH 1 1.05 1.12 
 
 
 
CHAPTER V                                                                                 RESULTS 
  
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI       Page 110 
Table – 6 
LOSS ON DRYING OF S.aromaticum LEAVES 
 
OBSERVATION NUMBER LOD %w/w 
1 9.12 
2 8.55 
3 8.51 
4 7.5 
5 8.78 
Minimum 7.50 
Average 8.49 
Maximum 9.12 
 
 
Table – 7 
EXTRACTIVE VALUES FOR S.aromaticum LEAVES 
 
SOLVENTS EXTRACTIVE VALUE (%) 
Petroleum ether 5.2 
Ethanol 9.8 
Water 10.6 
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5.2. PHYTOCHEMICAL STUDIES 
5.2.1. PRELIMINARY PHYTOCHEMICAL SCREENING: 
QUALITATIVE PHYTOCHEMICAL TEST 
 Preliminary phytochemical screening of the powdered mature leaves 
were carried out and the results are as follows (Table 8) 
 
TEST FOR ALKALOIDS 
Mayer’s test : Cream precipitate shows the presence of 
alkaloids 
Dragendorff’s test : Reddish brown precipitate shows the 
presence of alkaloids 
Hager’s test : Yellow precipitate shows the presence of 
alkaloids 
 
TEST FOR CARBOHYDRATES 
 
TEST FOR GLYCOSIDES 
Molish’s test : Appearance of purple colour shows the 
presence of carbohydrates. 
Fehling’s test : Formation of reddish brown precipitate shows 
the presence of free reducing sugars. 
Benedict’s test : Formation of reddish brown precipitate shows 
the presence of free reducing sugars. 
Keller killiani’s test 
 
: 
 
No reddish brown colour ring at the junction 
shows The Absence of cardiac glycosides. 
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TEST FOR PHYTO STEROL 
TEST FOR SAPONINS    :  Frothing occurs indicates the presence of 
     Saponins 
 
TEST FOR TANNINS 
Borntrager’s test 
 
Modified Borntrager’s 
test 
 
: 
 
No Appearance of  pink colour in 
ammonicallayer shows the Absence of 
anthraquinone glycosides 
No Appearance of  pink colour in ammonical 
layer shows the absence of anthraquinone 
glycosides 
Salkowski’s test : Appearance of red colour in lower layer shows 
the Presence of sterol 
Liebermann – 
Burchard’s test 
: Brown ring at the junction of two layers and  
green colour in the upper layer shows the 
Presence of sterols 
 
Ferric chloride test : Appearance of bluish black colour shows 
thepresenceof tannins 
Gold beater’s skin 
 
: Appearance of brown colour shows the 
presence of tannins 
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TOR T 
TEST FOR FLAVONOIDS 
 
Shinoda test : Purple colour shows the presence of flavonoids 
Alkaline reagent test : Yellow - orange colour shows the presence 
     of flavonoids 
Acid test   : Yellow – orange colour shows the  
     presence of flavonoids 
Zinc hydrochloride  : Red colour shows the presence of  
     flavonoid 
TEST FOR VOLATILE OIL:  Volatile oil obtained shows the presence of  
                                                 volatile oil 
TEST FOR PROTEINS AND FREE AMINOACIDS 
 
Millon’s test : Appearance of red colour on heating shows the 
presence of proteins 
Biuret test : Appearance of violet colour shows the presence 
of proteins 
Ninhydrin test 
  
: Formation of violet colour shows the presence 
of amino acids 
TEST FOR    
MUCILAGE 
: 
 
No appearance of reddish pink colour shows 
the presence of mucilage 
 
TEST FOR 
TERPENOIDS 
: Appearance of pink colour shows the presence 
of terpenoids 
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TEST FOR FIXED OIL : No translucent greasy spot  shows the  
     absence of  fixed oils 
 
Table – 8 
PRELIMINARY PHYTOCHEMICAL SCREENING OFLEAVES OF 
S.aromaticum 
S.NO TEST OBSERVATION 
I. ALKALOIDS 
 
Mayer’s reagent + 
 
Dragendorff’s reagent + 
 
Hager’s reagent + 
II. CARBOHYDRATES 
 
Molisch’s test + 
 
Fehling’s test + 
 
Benedict’s test + 
III. GLYCOSIDES 
 
Anthroquinone glycosides - 
 
Borntrager’s test - 
 
Modified Borndrager’s test - 
 
Cardiac glycosides 
 
Keller Killiani test - 
 
Raymond test - 
 
Legal test - 
IV. STEROLS 
 
Salkowski test + 
 
LibermanBurchard’s test + 
V. SAPONINS + 
VI. TANNINS 
 
Ferric chloride + 
 
Gold Beater’s skin test + 
VII. PROTEINS AND FREE AMINO ACIDS 
 
Millon’s test + 
 
Biuret test + 
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Ninhydrin test + 
VIII. MUCILAGE + 
IX. TERPENOIDS + 
X. FLAVONOIDS 
 
Shinoda test + 
 
Alkali test + 
 
Acid test + 
 
Zn/Hcl test + 
XI. VOLATILE OIL + 
XII. FIXED OIL - 
 
5.2.2 FLUORESCENCE ANALYSIS 
The fluorescence analysis of the leaf powder of S.aromaticum was 
studied. The results were as follows (Table -9) 
Table -9 
FLUORESCENCE ANALYSIS 
REAGENT OBSERVATION 
Powder as such Dark Green 
Powder + 50% Hydrochloric acid Yellowish Green 
Powder + 50% Nitric acid Light brown 
Powder + Petroleum ether Light orange 
Powder + 50% Sulphuric acid Dark brown 
Powder + 1N NaOH in water Dark green 
Powder + 1N NaOH in methanol Dark Green 
Powder +5% Ferric chloride solution Greenish brown 
Powder + Picric acid Flourescence green 
Powder + Chloroform Green 
Powder + 5% Iodine solution Green 
Powder + (HNO3 + NH3) Green 
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5.2.3 ESTIMATION OF FLAVONOID CONTENT  
Flavonoid content of extract in terms of quercetin by aluminium chloride 
was found to be 23.1mg/g. 
 
5.2.4 ESTIMATION OF TOTAL PHENOLIC CONTENT  
Total phenolic content ofextractin terms of gallicacid was found to be 
3.7mg/g. 
 
5.2.5 DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF 
S.aromaticum BY ENERGY DISPERSIVE X-RAY SPECTROMETER 
(EDS)ENERGY DISPERSIVE X-RAY SPECTRUM FOR S.aromaticum 
LEAVES 
Estimation of the elements like Cl, K, C, Ca, N, O, Fe, Mg, Al, and Si 
showed the following mg weight percentage and atomic percentage. 
FIGURE – 5 
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Table-10 
S.aromaticum LEAVES ELEMENTS WEIGHT & ATOMIC PERCENTAGE 
 
 
 
 
 
 
 
 
5.2.6 PHYSICO CHEMICAL EVALUATION OF ISOLATED VOLATILE OIL 
The Result of Phyico Chemical Analysis ,GC- MS Analysis Were As 
Follows, 
1.Percentage  Of Oil Obtained:2.5% 
2.Colour:Pale  Yellow 
3.Odour:Aromatic 
4.Taste:Pungent 
5.CharacteristicFeel:Greasy 
6.Solubility:Soluble In Petroleum Ether,Toluene,Chloroform,Ethanol. 
ImmisibleWith Water 
7.Refractive Index:1.533-1.359 
8.Specific Gravity:1.032-1.067 
9.Optical Rotation:-0050” to  - 1o53” 
 
Element Weight % Atomic % 
C K 78.45 82.99 
O K 21.23 16.86 
Na K 0.12 0.07 
Si K 0.05 0.02 
Cl K 0.08 0.03 
K K 0.06 0.02 
Totals 100.00  
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5.2.7.IDENTIFICATION OF COMPOUNDS PRESENT IN THE VOLATILE 
OIL OF LEAVES BY GC-MS ANALYSIS 
 The GC-MS analyscis of the isolated V.O indicated the presence of 
following constituents bycomparing with the instrument library. β- 
caryophyllene, Globulol α -pinene, α -terpinene,  β- bisabolene, 
Eugenol,Limonene,caryophylene oxide, cadinol, m.Cymene. 
 
FIGURE – 6- GC-MS PROFILE OF THE V O OF THE S.aromaticum 
LEAVES 
 
 
 
 
 
 
 
FIGURE -6 A 
SEM IMAGES OF NANOSPHERES OF S.aromaticum LEAF VOLATILE OIL 
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Preparation of nanospheres of volatile oil of the leaves of S.aromaticum 
(SALVONS): 
Encapsulation of VO using 1:1 (w/w) ratio EC/MC as the polymeric 
shell material was performed, resulted in the formation of milky white aqueous 
suspension. Analysis of the suspension by SEM revealed the presence of 
almost spherical particles with a dry size average diameter of 424± 102.6 nm. 
The process gave an EE of 77.5% with a loading level of 44.2% w/w. (Figure- 
6A) 
 
5.3 PHARMACOLOGICAL STUDIES 
5.3.1 Acute Toxicological Study Using Brine Shrimp Lethality Assay 
(BSLA) EFFECT OF VARIOUS CONC OF VOSAL ON Artemia nauplii 
In continuation of our efforts to verify the safety of VO, we performed 
Brine shrimp lethality assay (BSLA) using free swimming hatched out 
Artemianauplii which based on the ability to kill laboratory cultured brine 
shrimp. It was observed that 100% of mortality above 800 ppm for VO. LC50 
for VO was about 500ppm respectively in 24hrs. 100% mortality was 
observed at 3ppm for podophyllotoxin positive control. 
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TABLE 11 
ACUTE TOXICITY STUDY OF VOSAL (BSLA) 
CONCENTRATION 
(PPM) 
NUMBER 
OF 
LARVAE 
RELEASED 
NUMBER OF 
LARVAE 
DEAD AFTER 
24HRS 
MORTALITY 
(%) 
CORRECTED 
(%) 
MORTALITY 
USING 
ABBOT’S 
FORMULA 
100 
 
10 1 10 
10 
 
10 1 10 
10 1 10 
200 
10 1 10 
20 10 2 20 
10 3 30 
300 
10 2 20 
30 10 3 30 
10 4 40 
400 
10 4 40 
40 10 4 40 
10 4 40 
500 
10 5 50 
50 10 5 50 
10 5 50 
600 
10 6 60 
66.66 10 7 70 
10 7 70 
700 
10 8 80 
83.33 10 8 80 
10 9 90 
800 
10 9 90 
90 10 9 90 
10 9 90 
900 
10 8 80 
90 10 9 90 
10 10 100 
1000 
10 10 100 
100 10 10 100 
10 10 100 
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FIGURE  7 
ACUTE TOXICITY STUDY OF VOSAL 
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5.3 .2 EFFECT OF VOSAL ON MUTAGENESIS OF Drosophila 
melanogaster: 
Morphological changes like eye colour, spots in the wings, wing 
hairs, changes in the length and width of the wing, wing shape, abdomen 
length and total body length were observed in the F1 generation in the VO 
and formalin treated group. (Table 13). There was no observable 
morphological changes in the test drug treated but change of eye colour in the 
formalin treated. (Plate 1) 
TABLE-12 
EFFECT ON MUTAGENESIS OF VOSAL OFS.aromaticum on Drosophila 
melanogaster 
S. 
No 
Morphology 
Normal 
Flies 
Std 
Formaldehyde 
Exposed Flies 
(0.5% V/V) 
VO  treated Flies (µl/ml) 
1 2 4 
1. Eye Colour Red Dark pink Red Red Red 
2. 
 
 
 
 
 
Wing 
Shape 
Spots 
Hairs 
Length 
Width 
 
Elliptical 
Present 
Present 
100±1.1 
42±1.2 
 
Elliptical 
Present 
Present 
82±0.98 
36±1.78 
 
Elliptical 
Present 
Present 
95±1.41 
44±0.87 
 
Elliptical 
Present 
Present 
96±1.1 
43±2.1 
 
Elliptical 
Present 
Present 
99±1.3 
42±2.4 
3. 
Abdomen  
Length  
µm 
42±1.14 41±1.8 42±0.82 41±0.99 40±1.4 
4. 
Total  
Body  
Length  
µm 
97.3±2.02 95.8±1.9 94.2±0.56 95.66±1.22 95.93±1.72 
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5.3.3.In vivo EFFECT OF SALVONS ON THE TRANSGENIG Drosophila 
melanogaster  MUTANT WITH  Aβ42  INDUCED NEURODEGENERATION. 
5.3.4 EFFECT OF SALVONS ON LONGEVITY OF Aβ42 EXPRESSING 
Drosophila 
In the present study neuroprotective effect was evaluated using 
Drosophila AD model. This lifespan experiments Aβ42Drosophila showed a 
complete reduction in lifespan between 30 -40 days. All treated groups 
showed significant improvement of survival. 5µl/g showed maximum lifespan 
increase equivalent to the standard drug donepezil (Table 13) 
 
TABLE 13 
LONGEVITY ASSAY 
Name of  
the  
substance 
Conc/gm 
% survival 
Days 
10 20 30 40 50 60 70 
SALVONS 
1(µl) 100 55 32 5 0 0 0 
2.5(µl) 100 59 33 12 0 0 0 
5(µl) 100 62 36 19 0 0 0 
Donepezil 10mMol/gm 100 65 36 21 0 0 0 
POSITIVE 
1%DMSO 100 36 23 0 0 0 0 Control- 
Aβ 42 
Normal  
control 
Normal 
Diet 
100 100 95 87 73 68 47 
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FIGURE 8 
LONGEVITY ASSAY 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
%
 S
u
rv
iv
al
Days
LONGEVITY ASSAY
10 DAYS 20 DAYS 30 DAYS 40 DAYS 50 DAYS 60 DAYS 70 DAYS
CHAPTER V                                                                                 RESULTS 
  
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI       Page 125 
5.3.5 EFFECT OFSALVONS ON LOCOMOTOR FUNCTION BY CLIMBING 
ASSAY OF Aβ42  EXPRESSING  Drosophila: 
For locomotor abilities determination Aβ42 expressing Drosophila 
showed significant impaired locomotion from the age of day 9 onwards. 
SALVONS treated flies showed an improvement in locomotor activity dose 
dependently. 5µl/g conc showed improvement in the locomotion equivalent to 
the std drug donepezil. (Table-14, Fig-8) 
 
TABLE 14 
LOCOMOTION ASSAY 
 
 
 
 
 
 
 
 
 
 
EXTRACT CONC/gm 
DAYS 
12 16 19 23 
SALVONS 
1(µl) 51 38 23 10 
2.5(µl) 61 44 29 12 
5(µl) 70 58 37 20 
Aβ42 (+ve control) 1%DMSO 57 48 12 0 
Donepezil 10mMol/gm 72 60 38 25 
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FIGURE 9 
LOCOMOTION ASSAY 
 
 
           
       
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
Fl
ie
s 
th
at
 c
an
  c
lim
b
 u
p
to
 8
cm
 in
 1
0
 S
 %
Days
LOCOMOTION ASSAY
12 DAYS
16 DAYS
19 DAYS
23 DAYS
CHAPTER V                                                                                 RESULTS 
  
DEPARTMENT OF PHARMACOGNOSY,COP,MMC,MADURAI       Page 127 
5.3.6.PSEUDOPUPIL TECHNIQUE TO VISUALIZE THE RETINO 
RHABDOMERES IN ADULT EYES: 
 In this study the effect of Aβ42 expressing Drosophila on degeneration 
of retinal tissue which were mainly neurons. Aβ42 expressing Drosophila 
contained significantly more degenerating rhabdomeres compared with the 
normal fly. The number of degenerated rhabdomeres was 2±0.258. The 
treated group has significantly rescued rhabdomeres in each ommatidium with 
increase in number of count which reflected a preventive effect of the 
SALVONS on neurodegeneration. This effect was comparable to the standard 
drug donepezil         
            
TABLE 16 
EXPERIMENT RHABDOMERE COUNT 
Normal Control 7 
Aβ-42 expression 2±0.458 
Donepezil 4.45±0.89 
 
1µl 2.55±0.39 
SALVONS treated 2.5 µl 3.78±0.78 
 
5 µl 4.1±0.16 
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FIGURE 10 
PSEUDOPUPIL ASSAY 
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PLATE 13: PSEUDOPUPIL SHOWING RHABDOMERES 
CONTROL 
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Aβ 42 CONTROL 
 
 PSEUDOPUPIL SHOWING RHABDOMERES 
STANDARD DRUG TREATED 
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SALVONS TREATED 
 
 
5.3.7. EVALUVATION OF SURFACE ORGANIZATION OF OMMATIDIA IN 
ADULT EYES BY NAIL – POLISH IMPRINTS AND SEM: 
 To examine any disruption in the ordered arrays of the ommatidia in 
adult eyes  a novel, simple and inexpensive method that provides high quality 
images, comparable to those obtained by SEM, was adopted by using the nail 
polish technique. The peeled off layer being the exact replica of the eye 
showed the surface morphology. It was observed that there was a disruption 
in the regular array of the ommatidia in the Aβ42 expressing Drosophila. But 
the treated group and the standard drug treated group showed improvement 
of the surface with reduction in disruption. (Plate 14) 
 
 
 
PLATE 15 
NAIL POLISH IMPRESSION TECHNIQUE OMMATIDIA 
 
      NORMAL ORDERED ARRAY           Aβ 42 
 
      
 
DONEPZIL TREATED              VO TREATED 
 
              
       
 
 
 
 
PLATE 16 
EVALUATION OF OMMATIDA UNDER SEM 
NORMAL ORDER  ARRAY 
 
 
 
 
VO TREATED 
 
 
DONEPEZIL TREATED 
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DISCUSSION 
 
 The dissertation covers a study on widely available member of the 
family Myrtaceae known botanically Syzygium aromaticum commonly called 
as ‘clove’ in English and Kirambuin Tamil. The Syzygium aromaticum leaves 
of really do not have any match as a cheap natural and easily available plant. 
It was reported that Myrtaceae family members have phyto constituents useful 
in the treatment of various diseases and was also claimed that these plants 
merit detailed study which can prove useful in the discovery of lead 
compounds leading to novel and more efficacious drugs. Leaves of Syzygium 
aromaticum of this family, is traditionally known to be useful for the treatment 
of wide panel of diseases like and as antioxidant,  antimicrobial, 
antinociceptive, antiviral.Various scientific investigation of the leaves showed 
anti-diabetic activity, anti-microbial activity, antiulcer, analgesic, anti-
inflammatory ,anti-microbial, anti-oxidant, hepatoprotective, antihypertensive 
and wound healing activity. 
Clove is known to possess antibacterial properties and is used in 
various dental creams, tooth pastes, mouth washes, and throat sprays to 
cleanse bacteria. It is also used to relive pain from sore gums and improves 
overalldental health. In dentistry, eugenol in combination with zinc oxide 
isused for temporary filling of cavities.Clove is an anodyne (an agent that 
soothes or relives pain) for dental emergencies11. Cloves are aphrodisiac (an 
agent for arousing or increasing sexual desire or potency).Clove is used as an 
anti-inflammatory agent, due to itshigh content of flavonoids. Aroma therapists 
use pureclove oil to cure the symptoms of rheumatism andarthritis. Clove is 
used as a carminative, to increase hydrochloricacid in the stomach and to 
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improve peristalsis. Apply the paste of clove powder in honey to treat acne. 
Paste of clove powder in water promotes faster healing of cuts and bites. 
Cloves can effectively cure many digestive problems. It is having medicinal 
qualities to cure flatulence, loose motions, indigestion and nausea. Cloves are 
useful in relieving the symptoms of diarrhoea, gastric irritability and vomiting. 
  The economic aspect of this crop evidently proved that as commercial 
crop. In fact the revenue generated by this crop can be further magnified by 
many folds, if its medicinal applications are scientifically explored well. By a 
well-coordinated effort, we can properly exploit this plant. Therefore research 
on development of herbal products from this plant is required to be initiated 
immediately for exploring the unique potential of this crop which would also 
minimize the menacing wastage especially the leaves. It may be further 
envisaged that the revenue generated by this plant would easily exceed that 
generated by any major crop of the country even with a present level of 
traditional agro economic practices. Therefore a well-coordinated effort by the 
farmers, traders, scientist, technologists, extension workers, physician, 
administrators, and policy makers is required to be initiated to boost up the 
national economy as well as the proper exploitation of this for proper 
therapeutic purpose. The review of literature showed some lacuna exists in 
the pharmacological, phytochemical, and pharmacological studies in the 
leaves of S.aromaticum. 
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PHARMACOGNOSTICAL STUDIES :(PLATE 1-12) 
Morphological and micro morphological examination and 
characterization of medicinal plants have always been accorded due 
credentials in the pharmacological studies. There was no detailed 
pharmacognostical work has been carried out including botanical identity 
based on micro morphology in this leaves of this plant.  
 The application of morphological studies in drug analysis is pertinent in 
the field of crude drug authentication. It was studied for the leaf. Interpretation 
of the morphological characteristics based on different parameters, for the 
plant organs give a guideline for the diagnosis of the original plant and its 
adulterants. 
 Colour, size, shape, margin, texture, arrangement were observed and 
compared with previous data.  
 Microscopic techniques help to magnify the fine structure of minute 
objects and there by confirm the structural details of the plant drug. Though 
the microscopical evaluation cannot provide complete profile, still it can offer 
supporting evidences which when combined with other analytical parameters 
can be used to obtain full evidence for standardization and evaluation of 
herbal drugs. Consideration must therefore be given to the types of cells and 
cell inclusions and the manner in which they are distributed in different organ 
of the plants. The habit and habitat and the various morphological characters 
of the various parts have been studied after proper identification and 
authentication Leaves are simple,opposite,coriaceous,exstipulate,glabrous 
and aromatic.Size 7.5-12.3 x2.5-3.75 cm, Green in colour with entire margin 
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and cuneate base.Apex shortly or broadly blunty acuminate and  Petiole 2-3 
cm long. 
 T.S of  Midrib  grooved from above erect downward   flat  on the 
adaxial side, And convexity  on  the adaxial side.It is made up small 
rectangular thick wall uniseriate cells, covered by a thick cuticle. In surface 
view polygonal in shape amphistomatic / ranunculaceousfew in upper and 
more in lower epidermis. 
Transverse section of lamina shows an upper epidermis with a cuticle. 
Stomata are present on both the epidermis followed by two layer of palisade 
cells containing chloroplasts.  The spongy mesophyll is made up of 2 - 4 
layers of cells and seen in between the palisade and lower epidermis cells.  
Some of the cells of the spongy parenchyma contain oil contents as secretary 
cavities developed initially schizogenous but ultimately lysigenous at maturity 
with a breakdown of all the secretary cells within the gland lumen. Oil cavities 
located close to both surfaces, glandular and lined with epithelial like cells. 
Cells containing tannin are very common. The vascular system consists of a 
U shaped or almost closed circle of separate collateral vascular bundles.  
Small vascular bundles are scattered towards the peripheral region.  Each 
vascular bundle is encircled by a single row of bundle sheath. Distinct vein 
islets and vein terminals(some are forked) were clearly seen. 
 Scanning electron microscopy (SEM) study showed no diagnostic 
features and new kind of micro-constituents not previously recognized and 
apparently simple structure which may be extremely complex were observed. 
 The plant drugs are generally used in the powdered form where the 
macro morphology is generally destroyed, so the diagnosis of the plant 
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through the microscopical character is essential. The powdered crude drugs 
can be identified based on the presence or absence of different cell types. 
 In powdered microscopy observed ranunculaceous stomata, wavy 
walled epidermal cells, spiral annular vessels, phloem cells, sieve tube and 
companion cells, fibres, scizolysigenous secretary cells, tannin containing 
cells, parenchyma cells. (Fig-4) 
 Quantitative microscopy includes certain measurements to distinguish 
some closely related species which are not easily differentiated by general 
microscopy. The stomatal number is the oldest technique but a simple 
method of diagnosis of fragmentary leaf parts. The stomatal index is the 
percentage of stomata in relation to the epidermal cells. Both are very specific 
criteria for the identification and characterization of leafy drugs. Vein islet and 
vein termination number are another simple technique for distinguishing 
fragmentary specimens at specific levels. It is used as the distinguishing 
character for the leaf of the same species or different one.   
 Palisade Ratio is another criterion for identification and evaluation of 
herbal drugs.  This value remains constant within a range for a given plant 
species and is of diagnostic value in differentiating the species.  This value 
does not alter based on geographical variation and differs from species to 
species and that is why it is a very useful diagnostic feature for 
characterization and identification of different plant species. (Table 4) 
 The ash content of the crude drug is generally taken to be the residue 
remaining after incineration.  If usually represents the inorganic salts naturally 
occurring in the drug and adhering to it, but it may also involve the inorganic 
matter added for the purpose of adulteration. There is a considerable 
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difference within narrow limits in the case of individual drug.  Hence ash 
determination furnishes a basis for judging the identity and cleanliness of a 
drug and gives information related to its adulteration with inorganic matter. 
The ash or residue yielded by an organic chemical compound is a rule to 
measure the amount of inorganic matter, which is present as impurity. In most 
cases the inorganic matter is present in small amounts which are difficult to 
remove in the purification process and which are not objectionable if only 
traces are present. Ash values are helpful in determining the quality and purity 
of the crude drug in especially in powdered from. The acid insoluble ash is 
of more value to detect the earthy matter adhering to the drug. In this way one 
can obtain evidence of the presence of foreign matter, which likely to occur 
with root, rhizomes and also in pubescent leaves.  The water soluble ash is 
used to detect the presence of matter exhausted by water.  Insufficient drying 
favours spoilage by molds and bacteria and makes possible the enzymatic 
destruction of active principles (Table -5). Extractive values of crude drugs 
determine the amount of active constituents in a given amount of medicinal 
plant material when exhausted with solvents.  It is employed for that material 
for which no chemical or biological assay method exist.  As mentioned in 
different official books [Anonymous., 1996, Anonymous., 2006, Horborne JB., 
1973] the determination of water-soluble and alcohol soluble extractive, is 
used as means of evaluating crude drugs which are not readily estimated by 
other means.  The extraction of any crude with a particular solvent yields a 
solution containing different phytoconstituents. The composition of these 
phytoconstituents in that particular solvent depends upon the nature of the 
drug and solvent used. The use of single solvent can be the means of 
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providing preliminary information on the quality of a particular drug sample.  
The water soluble extractive values play an important role for the evaluation 
of crude drugs.  It can be used to indicate poor quality, adulteration with any 
unwanted material or incorrect processing of the crude drug during the drying, 
storage etc. The alcohol soluble extractive is also indicative for the same 
purpose as water soluble extractive values (Table -7). 
 Loss on drying at 105oC is determined as the presence of excess 
moisture is conductive to the promotion of mold and bacterial growth, and 
subsequently to deterioration and spoilage of the drug (Table -6) 
 
THE PRELIMINARY PHYTOCHEMICAL STUDIES: 
 The preliminary phytochemical screening reveals the presence of 
carbohydrates, proteins and amino acids, flavonoids, terpenoids, tannins, 
sterols, volatile oil. Fixed oil was found to be absent.(Table -8) 
 The reaction of drugs in powdered form in ordinary light and with 
filtered UV light is of importance in several cases by the luminosity in UV light 
by fluorescent analysis. Many flavonoids showed distinctive colours under 
UV light: Bright yellow (6-hydroxy flavanoids and flavones and some 
chalcones), dark brown (most flavanol glycosides, dark may be (isoflavones 
and flavonols). Hence this parameter can also be used as a diagnostic tool for 
the standardization of herbal drugs for the detection of adulterants in crude 
drugs (Table-9) (Harborne JB., 1973). 
 Determination of total flavonoid content was found to be 23.1µg/g 
.Determination of total phenolic content was found to be 3.7mg/g . 
 Identification of inorganic minerals of the leaves of 
S.aromaticumbyenergy dispersive X-ray spectrometer (EDS)showed the 
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presence of minerals Carbon (78.45%), Oxygen (21.23), Sodium (0.12%), 
Silica (0.05%), Chlorine (0.08%), Potassium (0.06%) (Table-10). No special 
characters were observed in SEM analysis. 
             Volatile oil was isolated from the leaves  (VOSAL) by hydrodistillation 
method (2.5%v/w). VOSAL is pale yellow, aromatic, pungent and greasy to 
touch. Soluble In petroleum ether, toluene, chloroform, ethanol and immisible 
with water. RI is 1.533-1.359Specific Gravity: 1.032-1.067and.Optical 
Rotation: Is -0050” to - 1o53. 
 The GC-MS analyscis of the isolated V.O indicated the presence of 
following constituents bycomparing with the instrument library. β- 
caryophyllene, Globulol α-pinene, α-terpinene, β-bisabolene, Eugenol, 
Limonene, caryophylene oxide, cadinol, m.Cymene. 
           Encapsulation of bioactive compounds represents a feasible and 
efficient approach to modulate drug release, increase the physical stability  of 
the active substances, protect them from the interactions with the 
environment, decrease their volatility, enhance their bioactivity, reduce 
toxicity, and A significantly large part of current literature on the encapsulation 
of EOs deals with micrometric size capsules, which are used for the protection 
of the active compounds against environmental factors (e.g., oxygen, light, 
moisture, and pH),to decrease oil volatility and to transform the oil into a 
powder. Encapsulation in nanometric particles is an alternative for overcoming 
these problems but additionally, due to the subcellular size, may increase the 
cellular absorption mechanisms and increasing bio efficacy improve patient 
compliance and convenience 
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Preparation of nanospheres of volatile oil of the leaves of S.aromaticum 
(SALVONS): 
Encapsulation of VO using 1:1 (w/w) ratio EC/MC as the polymeric 
shell material was performed, resulted in the formation of milky white aqueous 
suspension. Analysis of the suspension by SEM revealed the presence of 
almost spherical particles with a dry size average diameter of 424± 102.6 nm. 
The process gave an EE of 77.5% with a loading level of 44.2% w/w. 
 
PHARMACOLOGICAL STUDIES: 
ACUTE TOXICOLOGICAL STUDY: 
 In continuation of our efforts to verify the safety of VOSALwe 
performed Brine shrimp lethality assay (BSLA) using free swimming hatched 
out Artemianauplii which based on the ability to kill laboratory cultured brine 
shrimp . It was observed that 100% of mortality above 1000ppm .LC50 for 
were about 500ppm  in 24hrs. 100% mortality was observed at 3ppm for 
podophyllotoxin positive control. (Table-11).  
 In the investigation of effect on mutagenesis of the VOSAL we 
discussed about the need for performing the eye and wing spot assay along 
with description about D. melanogaster life cycle and reproduction, as a 
model organism in genetics and its similarity to humans. 
 The IInd stage larvae were selected for experiment. Formaldehyde 
(0.5%v/v) selected as standard chemical mutagen. VOSAL in the 
concentration (10, 20µl/ml) range were fed. After eclosion of the exposed flies 
from larvae stage, the phenotype changes, i.e., eye, color, wing hair, wing 
spot, wing shape, changes in the wing length and width, abdomen length and 
total body length were observed. Standard mutagen formaldehyde (0.5%v/v) 
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produced visual mutations (eye color become pink from brown) and 
additionally there were noticeable changes in the wing length and width, but 
remaining factors unchanged when compared to normal flies. The results are 
tabulated (Table-12).  The results observed were that the VOSAL at all 
concentration employed showed no significant morphological changes in the 
D. melanogaster on comparing formaldehyde exposed flies. This preliminary 
assay suggests its antimutagenic effect on D. melanogaster.  
 One of the important avenues in drug discovery that holds tremendous 
potential is use of model genetic organism such the fruit fly, D. melanogaster. 
This model represent intact living system was complex biological patterns and 
process can be readily examined. More over the similarity between mode of 
drug action, behavior and gene response in the D. melanogaster and 
mammalian systems, combined with the power of genetics, have recently 
made the fly a very attractive system to study fundamental neuro 
pharmacological processes relevant to human disease. The benefit that the 
use of model organisms like the fly, offers is speed, HTP and dramatically 
reduced overall cost that together result in an enhanced rate of drug 
discovery. It is also worthy to note that currently regulations regarding animal 
care and use (eg. IACUC) that applied to vertebrate animal research do not 
apply to Drosophila (Nichols.D.C.2006).   
 In this study we evaluated the neuro protective effect of SALVONS 
using Drosophila AD model. Initially we evaluated the effect of 5 and 20µl/g of 
the Drosophila media on food intake of Drosophila. We hypothesize 
SALVONS may also be effective in protecting neurons against beta-amyloid 
induced neuronal death and there is a lack of information relating to the in 
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vivo neuroprotective effect. In hope of finding phytoconstituents which could 
modulate APP cleavage and reduce neurotoxic effect from beta amyloid, the 
present study aimed to investigate the neuroprotective effects of SALVONS 
on beta amyloid induced neurodegeneration in Drosophila. Drosophila 
melanogaster was recently developed model organism for drug/medicinal 
plant screening for neurodegenerative diseases. It provides many unique 
features such as highly stable and fully known genetics highly conserved 
disease pathways, high throughput and very low comparative cost. Most of 
the genes implicated in human AD pathogenesis have Drosophila homologs, 
including amyloid precursor protein (APP) γ secretase and tau. But there are 
some dissimilarities, such as the absence of β-secrtase, which cause a defect 
in endogenous production of Aβ42. In this investigation the Drosophila models 
that overexpress human Aβ 42 would be used. The neurodegeneration would 
result in reduced lifespan, reduced locomotor activity and eye degeneration. 
These pathological phenotypes could be observed within few weeks, much 
faster than the development of these phenotypes in transgenic mice. Hence 
application of Drosophila as model of AD provides excellent tools for 
performing drug/herbal screens to identify small molecules and herbal formula 
that can suppress the toxicity associated with Aβ accumulation. 
Both concentration did not affect the food intake of Drosophila (data not 
shown) which ensured no experimental differences were due to the alteration 
of feeding behavior.  
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SALVONS prolonged the lifespan and improved locomotor function of 
Aβ42 Drosophila: 
 For lifespan experiment, Aβ42 Drosophila showed a reduction of 
lifespan by when compared to control. SALVONS treatment significantly 
improved the survival of Drosophila.5µl /g of Drosophila media, lifespan were 
increased comparable to the standard drug donepezil (p<0.001). 
 For the determination of locomotor ability, Aβ42 Drosophila showed 
significant impaired locomotion from age of day 9 onwards. SALVON Streated 
flies showed an improvement in the locomotor activity from age of days 12 to 
23. At day 12, 19, and 23 4µl/g of Drosophila media resulted in an 
improvement in locomotion. (p<0.001) when compared with the Aβ42 
Drosophila without treatment. 
 
RESCUED NEURODEGENERATION IN OMMATIDIA OF AΒ42 
EXPRESSING Drosophila: 
 We investigated the effect of Aβ42 Drosophila on degeneration of 
retinal tissue of, which were mainly neurons. Aβ42 Drosophila contained 
significantly more degenerating rhabdomeres compared to normal.  The 
number of degenerated rhabdomeres was 2 ± 0.458. Those treated with 
SALVONS had significantly rescued rhabdomeres in each ommatidium with 
an increase of rhabdomere count per ommatidium for the coc dose dependent 
by which reflected a preventive effect of SALVONS on neurodegeneration. 
The preventive effect was compared to donepezil, STD drug 10µmol/g of 
drosophila media. In which there was an increase of rhabdomeres count per 
ommatidium than the Aβ42 Drosophila. 
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 This shows it is an inexpensive and affordable and can be evaluated 
further for formulations. 
 In this present study, we demonstrated protection, rescue and most 
importantly restoration of the impaired movement activity (i.e climbing 
capability) Drosophila melanogaster, a valid model of AD. It provides a 
framework for future studies in AD patients. Elucidation of their mechanism of 
action will provide new insight for new targets.  
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CONCLUSION 
 
The present investigation high lights the pharmacognostical, 
phytochemical studies of the leaves of Syzygium aromaticum family  
Myrtaceaeand potential protective action against the beta amyloid induced 
Alzheimer disease in the Drosophila model and found more effective 
therapeutically than the synthetic counterpart without toxicity of its VOSAL. It 
is commonly called as clove widely cultivated and easily available plant. 
Ethnomedical information revealed that it is used in various ailments for long 
time all over the world. The tremendous economic potentiality of this cash 
crop remains neglected by the scientists, technologists, physician, traders, 
administrators, policy makers, farmers etc. 
The morphological evaluation showed the adherence of general 
characters to the family. 
  Detailed microscopical characters of the leaves showed the presence 
of usual leaf tissue arrangements along with syzolysegenous secretary 
cavities, ranaunculaceous stomata, two layers of palisade cells, U shaped 
bicollateralvasucular bundle and tanniniferous cells in ground tissue. Petiole 
microscopicalstructure showed U shaped vascular bundle and secretary 
cavities.  
 Scanning Electron Microscopic (SEM) observation SEM study of leaf 
provides detailed surface information. Adaxial and abaxial epidermal surface 
is smooth with no ornamentation. Quantitative parameters, Vein islet and 
termination numbers, stomatal number, stomatal index, palisade ratio, loss on 
drying, ash values, extractive values were determined and presented. 
Preliminary phytochemical screening showed the presence of carbohydrates, 
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proteins and amino acids, alkaloids, flavonoids, saponins, tannins, terpenoids, 
phytosterol, mucilage, volatile oil and absence of fixed oil. 
Quantitative inorganic elemental analysis by Energy dispersive X-Ray 
analysis (EDS) showed the presence of Carbon (78.45%), Oxygen (21.23), 
Sodium (0.12%), Silica (0.05%), Chlorine (0.08%), Potassium (0.06%). The 
pharmacologically important phytoconstituents polyphenols as total phenolic 
content and flavonoids were determined. 
 The VOSAL from the leaves was isolated and its GC-MS profile was 
presented. Presence of Eugenol (85.2%), Eugenal acetate 0.37%, β-
caryophylline 9%, α- humulene, vindiflorine, β- Phellondrene, m-cymene, 
limonene.   
Nanospheres of volatile oil of the leaves of S.aromaticum (SALVONS) 
was prepared. Encapsulation of VO using 1:1 (w/w) ratio EC/MC as the 
polymeric shell material was performed, resulted in the formation of milky 
white aqueous suspension. Analysis of the suspension by SEM revealed the 
presence of almost spherical particles with a dry size average diameter of 
424± 102.6 nm. The process gave an EE of 77.5% with a loading level of 
44.2% w/w. 
 The 3R’s ethical principle (Reduction, Refinement and Replacement) 
was implemented that help to minimize harms to vertebrate animals used in 
science. 
Acute toxicity study was performed by bench top bioassay BSLA (Brine 
Shrimp Lethality Assay) LC50 of VOSAL was found to be 500ppm and are 
non-toxic. (Standard toxin podophyllotoxin showed 100% mortality at 3ppm 
itself.) Effect of VOSAL on mutagenesis in vivo was investigated first time for 
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using Drosophila model organism to fill up the lacuna and found no effect on 
mutagenesis. 
In our study we used valid model genetic organism Drosophila 
melanogaster as a system biology research approach since it places specific 
molecular targets within a context of overall biochemical reaction. The 
similarity between mode of drug action, behavior, and gene response in  
model organisms and mammalian systems, combined with the power of 
genetics made  them very attractive system to study fundamental 
neurophamacological processes relevant to human diseases especially the 
Alzheimer, a common progressive neurodegenerative disorder for which at 
present no causal treatment is available .     We investigated the in vivo 
neuroprotection of the SALVONS on the representative of Alzheimer disease 
model of transgenic Drosophila by overexpression of beta amyloid protein, 
Aβ42 .In the present study we have presented the first evidence that the 
SALVONS could significantly ameliorate the adverse morphological changes 
from Aβ42 protein in Drosophila, as indicated by prolonging the lifespan, by 
improving locomotor abilities and rescuing neurodegeneration in ommatidia 
Aβ expressing Drosophila which is comparable with donepezil. So it 
demonstrated the novel use of SALVONS against Aβ induced 
neurodegeneration which may be mediated through the multiple components 
of the VOSAL. Based on this findings we suggest developing VOSAL as a 
potential therapeutic intervention for neurodegenerative diseases like 
Alzheimer’s disease. VOSAL effectively protects, rescue and most importantly 
restore the impaired movement activity (i.e climbing capability) in Drosophila 
melanogaster, a valid model of AD. It provides a framework for future studies 
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to assess to suppress oxidative stress and to restore and or maintain 
locomotor activity in AD patients. Elucidation of their mechanism of action will 
provide new insight for new targets.  
In conclusion, the leaves of S.aromaticum may be further investigated 
for the development as novel non toxic preventive/treatment interventions for 
life threatening neurodegenerative diseases such as AD.  But to confirm our 
findings further investigations of these effects to mammalian model is 
necessary. Further pharmacokinetic studies are also required to understand 
the post metabolism ingredients along with the clinical efficacy and safety in 
human. 
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